Browse by UCL Departments and Centres
![[up]](/style/images/multi_up.png)
Up a levelGroup by: Author | Type
Number of items: 383.
A
Aaboud, M;
Aad, G;
Abbott, B;
Abdinov, O;
Abeloos, B;
Abhayasinghe, DK;
Abidi, SH;
... Zwalinski, L; + view all
(2019)
Searches for scalar leptoquarks and differential cross-section measurements in dilepton-dijet events in proton-proton collisions at a centre-of-mass energy of root s=13TeV with the ATLAS experiment.
The European Physical Journal C
, 79
, Article 733. 10.1140/epjc/s10052-019-7181-x.
|
 |
|
Abeti, R;
Baccaro, A;
Giunti, P;
(2019)
Mitochondrial Dysfunction in Friedreich Ataxia.
In: Ahmad, SI, (ed.)
Handbook of Mitochondrial Dysfunction.
CRC Press: Boca Raton, FL, USA.
|
|
Abeyakoon, O;
Latifoltojar, A;
Gong, F;
Papoutsaki, M-V;
Chowdhury, R;
Glaser, M;
Jeraj, H;
... Punwani, S; + view all
(2019)
Hyperpolarised 13C MRI: a new horizon for non-invasive diagnosis of aggressive breast cancer.
BJR case reports
, 5
(3)
, Article 20190026. 10.1259/bjrcr.20190026.
|
|
|
Adeleke, S;
Latifoltojar, A;
Sidhu, H;
Galazi, M;
Shah, TT;
Clemente, J;
Davda, R;
... Punwani, S; + view all
(2019)
Localising occult prostate cancer metastasis with advanced imaging techniques (LOCATE trial): a prospective cohort, observational diagnostic accuracy trial investigating whole-body magnetic resonance imaging in radio-recurrent prostate cancer.
BMC Medical Imaging
, 19
, Article 90. 10.1186/s12880-019-0380-y.
|
|
|
Agostinelli, C;
Akarca, AU;
Ramsay, A;
Rizvi, H;
Rodriguez-Justo, M;
Pomplun, S;
Proctor, I;
... Marafioti, T; + view all
(2019)
Novel markers in pediatric-type follicular lymphoma.
Virchows Archiv
10.1007/s00428-019-02681-y.
(In press).
|
|
|
Ahmad, SS;
Crittenden, MR;
Tran, PT;
Kluetz, PG;
Blumenthal, GM;
Bulbeck, H;
Baird, RD;
... Sharma, RA; + view all
(2019)
Clinical Development of Novel Drug–Radiotherapy Combinations.
Clinical Cancer Research
, 25
(5)
pp. 1455-1461.
10.1158/1078-0432.CCR-18-2466.
|
|
Ahmedzai, SH;
Snowden, JA;
Ashcroft, AJ;
Cairns, DA;
Williams, C;
Hockaday, A;
Cavenagh, JD;
... Cook, G; + view all
(2019)
Patient-Reported Outcome Results From the Open-Label, Randomized Phase III Myeloma X Trial Evaluating Salvage Autologous Stem-Cell Transplantation in Relapsed Multiple Myeloma.
Journal of Clinical Oncology
, 37
(19)
pp. 1617-1628.
10.1200/jco.18.01006.
|
|
|
Akintonde, A;
Grimes, H;
Moinuddin, S;
Sharma, RA;
McClelland, J;
Thielemans, K;
(2019)
EP-2067 Data driven region of interest respiratory surrogate signal extraction from CBCT data.
Presented at: 38th Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO), Milan, Italy.
|
|
Akintonde, A;
Thielemans, K;
Sharma, R;
Mouches, P;
Mory, C;
Rit, S;
McClelland, J;
(2019)
Respiratory motion model derived from CBCT projection data.
In:
Proceedings of the 19th International Conference on the Use of Computers in Radiation Therapy.
ICCR
(In press).
|
|
Al-Mossawi, H;
Yager, N;
Taylor, CA;
Lau, E;
Danielli, S;
de Wit, J;
Gilchrist, J;
... Fairfax, BP; + view all
(2019)
Context-specific regulation of surface and soluble IL7R expression by an autoimmune risk allele.
Nature Communications
, 10
, Article 4575. 10.1038/s41467-019-12393-1.
|
|
|
Alifrangis, C;
McGovern, U;
Freeman, A;
Powles, T;
Linch, M;
(2019)
Molecular and histopathology directed therapy for advanced bladder cancer.
Nature Reviews Urology
, 16
(8)
pp. 465-483.
10.1038/s41585-019-0208-0.
|
|
|
Alzoubaidi, D;
Graham, D;
Bassett, P;
Magee, C;
Everson, M;
Banks, M;
Novelli, M;
... Haidry, R; + view all
(2019)
Comparison of two multiband mucosectomy devices for endoscopic resection of Barrett's esophagus-related neoplasia.
Surgical Endoscopy
, 33
pp. 3665-3672.
10.1007/s00464-018-06655-0.
|
|
|
Alzoubaidi, D;
Ragunath, K;
Wani, S;
Penman, ID;
Trudgill, NJ;
Jansen, M;
Banks, M;
... Haidry, R; + view all
(2019)
Quality indicators for Barrett's endotherapy (QBET): UK consensus statements for patients undergoing endoscopic therapy for Barrett's neoplasia.
Frontline Gastroenterology
10.1136/flgastro-2019-101247.
|
|
|
Amary, F;
Markert, E;
Berisha, F;
Ye, H;
Gerrand, C;
Cool, P;
Tirabosco, R;
... Flanagan, AM; + view all
(2019)
FOS Expression in Osteoid Osteoma and Osteoblastoma: A Valuable Ancillary Diagnostic Tool.
American Journal of Surgical Pathology
, 43
(12)
pp. 1661-1667.
10.1097/PAS.0000000000001355.
|
|
Amary, F;
Perez-Casanova, L;
Ye, H;
Cottone, L;
Strobl, A-C;
Cool, P;
Miranda, E;
... Flanagan, AM; + view all
(2019)
Synovial chondromatosis and soft tissue chondroma: extraosseous cartilaginous tumor defined by FN1 gene rearrangement.
Modern Pathology
, 32
pp. 1762-1771.
10.1038/s41379-019-0315-8.
|
|
Anandagoda, N;
Willis, JC;
Hertweck, A;
Roberts, LB;
Jackson, I;
Gökmen, MR;
Jenner, RG;
... Lord, GM; + view all
(2019)
microRNA-142-mediated repression of phosphodiesterase 3B critically regulates peripheral immune tolerance.
Journal of Clinical Investigation
10.1172/JCI124725.
(In press).
|
|
|
Ankcorn, MJ;
Fox, TA;
Ijaz, S;
Nicholas, C;
Houston, E;
Longair, I;
Suri, D;
... Sekhar, M; + view all
(2019)
Characterising the risk of Hepatitis E virus infection in haematological malignancies: a UK prospective prevalence study.
British Journal of Haematology
, 186
(1)
pp. 191-195.
10.1111/bjh.15796.
|
|
Antas, P;
Novellasdemunt, L;
Kucharska, A;
Massie, I;
Carvalho, J;
Oukrif, D;
Nye, E;
... Li, VSW; + view all
(2019)
SH3BP4 Regulates Intestinal Stem Cells and Tumorigenesis by Modulating β-Catenin Nuclear Localization.
Cell Reports
, 26
(9)
2266-2273.e4.
10.1016/j.celrep.2019.01.110.
|
|
|
Aswendt, M;
Vogel, S;
Schaefer, C;
Jathoul, A;
Pule, M;
Hoehn, M;
(2019)
Quantitative in vivo dual-color bioluminescence imaging in the mouse brain.
Neurophotonics
, 6
(2)
, Article 025006. 10.1117/1.NPh.6.2.025006.
|
|
|
Attard, G;
Conteduca, V;
Wetterskog, D;
(2019)
A multimodal approach to outcome prediction in metastatic castration-resistant prostate cancer by integrating functional imaging and plasma DNA analysis.
JCO Precision Oncology
10.1200/PO.18.00302.
(In press).
|
|
Attard, G;
Jayaram, A;
Wingate, A;
Wetterskog, K;
(2019)
Plasma Androgen Receptor Copy Number Status at Emergence of Metastatic Castration-Resistant Prostate Cancer: A Pooled Multicohort Analysis.
JCO Precision Oncology
, 3
10.1200/PO.19.00123.
|
|
Attard, G;
Wetterskog, D;
Jayaram, A;
Wingate, A;
(2019)
Plasma AR status and cabazitaxel in heavily-treated metastatic castration-resistant prostate cancer.
European Journal of Cancer
, 116
pp. 158-168.
10.1016/j.ejca.2019.05.007.
|
|
Avenali, M;
Toffoli, M;
Mullin, S;
McNeil, A;
Hughes, DA;
Mehta, A;
Blandini, F;
(2019)
Evolution of prodromal parkinsonian features in a cohort of GBA mutation-positive individuals: a 6-year longitudinal study.
Journal of Neurology, Neurosurgery & Psychiatry
10.1136/jnnp-2019-320394.
(In press).
|
B
|
Bailey, C;
Bourne, RM;
Siow, B;
Johnston, EW;
Brizmohun Appayya, M;
Pye, H;
Heavey, S;
... Panagiotaki, E; + view all
(2019)
VERDICT MRI validation in fresh and fixed prostate specimens using patient-specific moulds for histological and MR alignment.
NMR in Biomedicine
, Article e4073. 10.1002/nbm.4073.
(In press).
|
|
|
Baker, A-M;
Gabbutt, C;
Williams, MJ;
Cereser, B;
Jawad, N;
Rodriguez-Justo, M;
Jansen, M;
... Wright, NA; + view all
(2019)
Crypt fusion as a homeostatic mechanism in the human colon.
Gut
10.1136/gutjnl-2018-317540.
(In press).
|
|
|
Banerjee, G;
Chan, E;
Ambler, G;
Wilson, D;
Cipolotti, L;
Shakeshaft, C;
Cohen, H;
... Vahidassr, D; + view all
(2019)
Effect of small-vessel disease on cognitive trajectory after atrial fibrillation-related ischaemic stroke or TIA.
Journal of Neurology
, 266
(5)
pp. 1250-1259.
10.1007/s00415-019-09256-6.
|
|
|
Banks, M;
Graham, D;
Jansen, M;
Gotoda, T;
Coda, S;
di Pietro, M;
Uedo, N;
... Dinis-Ribeiro, M; + view all
(2019)
British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma.
Gut
10.1136/gutjnl-2018-318126.
(In press).
|
|
|
Barber, PR;
Weitsman, G;
Lawler, K;
Barrett, J;
Rowley, M;
Rodriguez-Justo, M;
Fisher, D;
... Ng, T; + view all
(2019)
HER2-HER3 heterodimer quantification by FRET-FLIM and patient subclass analysis of the COIN colorectal trial.
JNCI: Journal of the National Cancer Institute
10.1093/jnci/djz231.
(In press).
|
|
|
Barrington, C;
Georgopoulou, D;
Pezic, D;
Varsally, W;
Herrero, J;
Hadjur, S;
(2019)
Enhancer accessibility and CTCF occupancy underlie asymmetric TAD architecture and cell type specific genome topology.
Nature Communications
, 10
, Article 2908. 10.1038/s41467-019-10725-9.
|
|
|
Barrington, SF;
Phillips, EH;
Counsell, N;
Hancock, B;
Pettengell, R;
Johnson, P;
Townsend, W;
... Radford, J; + view all
(2019)
Positron Emission Tomography Score Has Greater Prognostic Significance Than Pretreatment Risk Stratification in Early-Stage Hodgkin Lymphoma in the UK RAPID Study.
Journal of Clinical Oncology
, 37
(20)
pp. 1732-1741.
10.1200/JCO.18.01799.
|
|
|
Barrington, SF;
Phillips, EH;
Counsell, N;
Radford, J;
(2019)
Reply to H.J.A. Adams et al and C. Kobe et al.
Journal of Clinical Oncology
, 37
(34)
pp. 3325-3326.
10.1200/JCO.19.02056.
|
|
Barton, J;
Pacey, K;
Jain, N;
Kasia, T;
Edwards, D;
Thevanesan, C;
Straathof, K;
... Anderson, J; + view all
(2019)
Establishment and phenotyping of neurosphere cultures from primary neuroblastoma samples.
F1000Research
, 8
, Article 823. 10.12688/f1000research.18209.1.
|
|
|
Baumhoer, D;
Amary, F;
Flanagan, AM;
(2019)
An update of molecular pathology of bone tumors. Lessons learned from investigating samples by next generation sequencing.
Genes, Chromosomes and Cancer
, 58
(2)
pp. 88-99.
10.1002/gcc.22699.
|
|
Baumhoer, D;
Kovac, M;
Sperveslage, J;
Ameline, B;
Strobl, A-C;
Krause, A;
Trautmann, M;
... Hartmann, W; + view all
(2019)
Activating mutations in the MAP-kinase pathway define non-ossifying fibroma of bone.
The Journal of Pathology
, 248
(1)
pp. 116-122.
10.1002/path.5216.
|
|
Bazarbachi, A;
Boumendil, A;
Finel, H;
Mohty, M;
Castagna, L;
Blaise, D;
Peggs, KS;
... Sureda, A; + view all
(2019)
Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party.
Cancer
, 125
(1)
pp. 90-98.
10.1002/cncr.31755.
|
|
Beaton, L;
Bandula, S;
Gaze, MN;
Sharma, RA;
(2019)
How rapid advances in imaging are defining the future of precision radiation oncology.
British Journal of Cancer
, 120
pp. 779-790.
10.1038/s41416-019-0412-y.
|
|
Beaton, L;
Bergman, A;
Nichol, A;
Aparicio, M;
Wong, G;
Gondara, L;
Speers, C;
... Tyldesley, S; + view all
(2019)
Cardiac death after breast radiotherapy and the QUANTEC cardiac guidelines.
Clinical and Translational Radiation Oncology
, 19
pp. 39-45.
10.1016/j.ctro.2019.08.001.
|
|
|
Beaton, L;
Tregidgo, HFJ;
Znati, SA;
Forsyth, S;
Clarkson, MJ;
Bandula, S;
Chouhan, M;
... Sharma, RA; + view all
(2019)
VEROnA Protocol: A Pilot, Open-Label, Single-Arm, Phase 0, Window-of-Opportunity Study of Vandetanib-Eluting Radiopaque Embolic Beads (BTG-002814) in Patients With Resectable Liver Malignancies.
JMIR Research Protocols
, 8
(10)
, Article e13696. 10.2196/13696.
|
|
|
Beedham, W;
Peck, G;
Richardson, S;
Tsang, K;
Fertleman, M;
Shipway, D;
(2019)
Head injury in the elderly – an overview for the physician.
Clinical Medicine
, 19
(2)
pp. 177-184.
10.7861/clinmedicine.19-2-177.
|
|
Behjati, S;
Green, K;
Cheng, CWD;
(2019)
Fifteen Minute Consultation: Obvious and Not-So-Obvious Mediastinal Masses.
Archives of Disease in Childhood - Education & Practice edition
10.1136/archdischild-2018-315269.
|
|
|
Bell, CG;
Lowe, R;
Adams, PD;
Baccarelli, AA;
Beck, S;
Bell, JT;
Christensen, BC;
... Rakyan, VK; + view all
(2019)
DNA methylation aging clocks: challenges and recommendations.
Genome Biology
, 20
, Article 249. 10.1186/s13059-019-1824-y.
|
|
|
Bell, L;
Potts, H;
Williamson, E;
(2019)
P-17
Improving engagement in a health app: considerations in
designing a Micro-Randomised Trial.
Presented at: The 5th International Clinical Trials Methodology Conference (ICTMC 2019).
|
|
|
Beltran, M;
Tavares, M;
Justin, N;
Khandelwal, G;
Ambrose, J;
Foster, BM;
Worlock, KB;
... Jenner, RG; + view all
(2019)
G-tract RNA removes Polycomb repressive complex 2 from genes.
Nature Structural & Molecular Biology
, 26
pp. 899-909.
10.1038/s41594-019-0293-z.
|
|
Bennett, CL;
Ambler, CA;
(2019)
Editorial: Langerhans Cells and How Skin Pathology Reshapes the Local Immune Environment.
Frontiers in Immunology
, 10
, Article 139. 10.3389/fimmu.2019.00139.
|
|
|
Bentham, RB;
Bryson, K;
Szabadkai, G;
(2019)
Biclustering Analysis of Co-regulation Patterns in Nuclear-Encoded Mitochondrial Genes and Metabolic Pathways.
Cancer Metabolism
, 1928
pp. 469-478.
10.1007/978-1-4939-9027-6_24.
|
|
Bi, WL;
Hosny, A;
Schabath, MB;
Giger, ML;
Birkbak, NJ;
Mehrtash, A;
Allison, T;
... Aerts, HJWL; + view all
(2019)
Artificial intelligence in cancer imaging: Clinical challenges and applications.
CA: A Cancer Journal for Clinicians
, 69
(2)
pp. 127-157.
10.3322/caac.21552.
|
|
|
Bilanges, B;
Posor, Y;
Vanhaesebroeck, B;
(2019)
PI3K isoforms in cell signalling and vesicle trafficking.
Nature Reviews Molecular Cell Biology
, 20
pp. 515-534.
10.1038/s41580-019-0129-z.
|
|
Biswas, D;
Birkbak, NJ;
Rosenthal, R;
Hiley, CT;
Lim, EL;
Papp, K;
Boeing, S;
... TRACERx Consortium; + view all
(2019)
A clonal expression biomarker associates with lung cancer mortality.
Nature Medicine
, 25
pp. 1540-1548.
10.1038/s41591-019-0595-z.
|
|
Black, JR;
Goldin, RD;
Foxton, M;
Marafioti, T;
Akarca, AU;
Pria, AD;
Brock, C;
... Pinato, DJ; + view all
(2019)
PD-L1 expressing granulomatous reaction as an on-target mechanism of steroid-refractory immune hepatotoxicity.
Immunotherapy
, 11
(7)
pp. 585-590.
10.2217/imt-2018-0187.
|
|
Boire, A;
Coffelt, SB;
Quezada, SA;
Vander Heiden, MG;
Weeraratna, AT;
(2019)
Tumour Dormancy and Reawakening: Opportunities and Challenges.
Trends in Cancer
, 5
(12)
pp. 762-765.
10.1016/j.trecan.2019.10.010.
|
|
Boned Del Río, I;
Young, LC;
Sari, S;
Jones, GG;
Ringham-Terry, B;
Hartig, N;
Rejnowicz, E;
... Rodriguez-Viciana, P; + view all
(2019)
SHOC2 complex-driven RAF dimerization selectively contributes to ERK pathway dynamics.
Proceedings of the National Academy of Sciences of the United States of America
10.1073/pnas.1902658116.
(In press).
|
|
|
Boned del Río, Isabel;
(2019)
Therapeutic potential of SHOC2 via its selective contribution of the ERK pathway activation.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Bray, TJP;
Lopes, A;
Fisher, C;
Ciurtin, C;
Sen, D;
Hall-Craggs, MA;
(2019)
Sacroiliac Joint Ankylosis In Young Spondyloarthritis Patients Receiving Biologic Therapy: Observation of Serial MRI scans.
Arthritis and Rheumatology
, 71
(4)
pp. 594-598.
10.1002/art.40750.
|
|
Breeze, CE;
Reynolds, AP;
van Dongen, J;
Dunham, I;
Lazar, J;
Neph, S;
Vierstra, J;
... Beck, S; + view all
(2019)
eFORGE v2.0: updated analysis of cell type-specific signal in epigenomic data.
Bioinformatics
10.1093/bioinformatics/btz456.
(In press).
|
|
|
Bridgewater, J;
(2019)
Systemic treatment of biliary tract cancer: now we have evidence.
Annals of Oncology
, 30
(12)
pp. 1851-1852.
10.1093/annonc/mdz441.
|
|
Brown, P;
Tan, A-C;
El-Esawi, MA;
Liehr, T;
Blanck, O;
Gladue, DP;
Almeida, GMF;
... Shalchyan, V; + view all
(2019)
Large expert-curated database for benchmarking document similarity detection in biomedical literature search.
Database
pp. 1-66.
10.1093/database/baz085.
|
|
Budczies, J;
Allgäuer, M;
Litchfield, K;
Rempel, E;
Christopoulos, P;
Kazdal, D;
Endris, V;
... Stenzinger, A; + view all
(2019)
Optimizing panel-based tumor mutational burden (TMB) measurement.
Annals of Oncology
, 30
(9)
pp. 1496-1506.
10.1093/annonc/mdz205.
|
|
|
Bugeja, S;
Mistry, K;
Yim, IHW;
Tamimi, A;
Roberts, N;
Mundy, AR;
(2019)
A new Urethral Catheterisation Device (UCD) to manage Difficult Urethral Catheterisation.
World Journal of Urology
, 37
(4)
pp. 595-600.
10.1007/s00345-018-2499-9.
|
|
|
Burt, R;
Dey, A;
Aref, S;
Aguiar, M;
Akarca, A;
Bailey, K;
Day, W;
... Fielding, AK; + view all
(2019)
Activated stromal cells transfer mitochondria to rescue acute lymphoblastic leukemia cells from oxidative stress.
Blood
, 134
(17)
pp. 1415-1429.
10.1182/blood.2019001398.
|
|
Burt, R;
Warcel, D;
Fielding, AK;
(2019)
Blinatumomab, a bispecific B-cell and T-cell engaging antibody, in the treatment of B-cell malignancies.
Human Vaccines & Immunotherapeutics
, 15
(3)
pp. 594-602.
10.1080/21645515.2018.1540828.
|
|
Buzzetti, E;
Hall, A;
Ekstedt, M;
Manuguerra, R;
Guerrero Misas, M;
Covelli, C;
Leandro, G;
... Tsochatzis, EA; + view all
(2019)
Collagen proportionate area is an independent predictor of long‐term outcome in patients with non‐alcoholic fatty liver disease.
Alimentary Pharmacology and Therapeutics
, 49
(9)
pp. 1214-1222.
10.1111/apt.15219.
|
C
|
Cailleau, T;
Adams, LR;
Arora, N;
Kang, G-D;
Masterson, L;
Patel, N;
Hartley, JA;
... Howard, PW; + view all
(2019)
Potentiation of PBD Dimers by Lipophilicity Manipulation.
Current Topics in Medicinal Chemistry
, 19
(9)
pp. 741-752.
10.2174/1568026619666190401112517.
|
|
Calaminus, G;
Jenney, M;
Hjorth, L;
Baust, K;
Bernstein, M;
Bielack, S;
Vos, PD;
... Nagarajan, R; + view all
(2019)
Quality of Life of Patients With Osteosarcoma in the European American Osteosarcoma Study-1 (EURAMOS-1): Development and Implementation of a Questionnaire Substudy.
JMIR Research Protocols
, 8
(9)
, Article e14406. 10.2196/14406.
|
|
|
Cappellini, MD;
Porter, J;
Origa, R;
Forni, GL;
Voskaridou, E;
Galacteros, F;
Taher, AT;
... Hermine, O; + view all
(2019)
Sotatercept, a novel transforming growth factor beta ligand trap, improves anemia in beta-thalassemia: a phase II, open-label, dose-finding study.
Haematologica
, 104
(3)
pp. 477-484.
10.3324/haematol.2018.198887.
|
|
|
Carter, Thomas James;
(2019)
Magnetic Hyperthermia for the Treatment of Glioblastoma.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Carters, R;
Cheraghchi-Bashi, A;
Westhorpe, A;
Yu, S;
Shanneik, Y;
Seraia, E;
Ouaret, D;
... Sharma, RA; + view all
(2019)
Identification of anticancer drugs to radiosensitise BRAF-wild-type and mutant colorectal cancer.
Cancer Biology & Medicine
, 16
(2)
pp. 234-246.
10.20892/j.issn.2095-3941.2018.0284.
|
|
|
Chambers, P;
Jani, Y;
Wei, L;
Kipps, E;
Forster, MD;
Wong, ICK;
(2019)
Patient Factors and their Impact on Neutropenic Events: A Systematic review and meta-analysis.
Supportive Care in Cancer
, 27
(7)
pp. 2413-2424.
10.1007/s00520-019-04773-6.
|
|
Chan, JKY;
Gil-Farina, I;
Johana, N;
Rosales, C;
Tan, YW;
Ceiler, J;
Mcintosh, J;
... Mattar, CNZ; + view all
(2019)
Therapeutic expression of human clotting factors IX and X following adeno-associated viral vector-mediated intrauterine gene transfer in early-gestation fetal macaques.
FASEB Journal
, 33
(3)
pp. 3954-3967.
10.1096/fj.201801391R.
|
|
|
Chan, TA;
Yarchoan, M;
Jaffee, E;
Swanton, C;
Quezada, SA;
Stenzinger, A;
Peters, S;
(2019)
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic.
Annals of Oncology
, 30
(1)
pp. 44-56.
10.1093/annonc/mdy495.
|
|
|
Chandy, E;
Taylor, H;
Gaito, S;
Wells, E;
Jones, C;
Meehan, C;
Burland, H;
... Mandeville, H; + view all
(2019)
Hypofractionated Stereotactic Ablative Radiotherapy for Recurrent or Oligometastatic Tumours in Children and Young Adults.
Clinical Oncology
10.1016/j.clon.2019.11.005.
(In press).
|
|
|
Chang, J-M;
Floden, EW;
Herrero, J;
Gascuel, O;
Di Tommaso, P;
Notredame, C;
(2019)
Incorporating alignment uncertainty into Felsenstein’s phylogenetic bootstrap to improve its reliability.
Bioinformatics
10.1093/bioinformatics/btz082.
(In press).
|
|
Chauhan, N;
Mulcahy, MF;
Salem, R;
Benson Iii, AB;
Boucher, E;
Bukovcan, J;
Cosgrove, D;
... Sharma, RA; + view all
(2019)
TheraSphere Yttrium-90 Glass Microspheres Combined With Chemotherapy Versus Chemotherapy Alone in Second-Line Treatment of Patients With Metastatic Colorectal Carcinoma of the Liver: Protocol for the EPOCH Phase 3 Randomized Clinical Trial.
JMIR Research Protocols
, 8
(1)
, Article e11545. 10.2196/11545.
|
|
Chavda, SJ;
Maciocia, PM;
Mesiri, P;
Counsell, N;
Kothari, J;
Bird, A;
Mariner, C;
... Yong, K; + view all
(2019)
A new prognostic model for myeloma patients relapsing from upfront autologous transplantation based on ISS and PFS1.
British Journal of Haematology
, 185
(2)
pp. 350-353.
10.1111/bjh.15487.
|
|
Chemaly, RF;
Hill, JA;
Voigt, S;
Peggs, KS;
(2019)
In vitro comparison of currently available and investigational antiviral agents against pathogenic human double-stranded DNA viruses: A systematic literature review.
Antiviral Research
, 163
pp. 50-58.
10.1016/j.antiviral.2019.01.008.
|
|
|
Chemi, F;
Rothwell, DG;
McGranahan, N;
Gulati, S;
Abbosh, C;
Pearce, SP;
Zhou, C;
... TRACERx Consortium, .; + view all
(2019)
Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse.
Nature Medicine
, 25
pp. 1534-1539.
10.1038/s41591-019-0593-1.
|
|
Chen, W;
Morabito, SJ;
Kessenbrock, K;
Enver, T;
Meyer, KB;
Teschendorff, AE;
(2019)
Single-cell landscape in mammary epithelium reveals bipotent-like cells associated with breast cancer risk and outcome.
Communications Biology
, 2
, Article 306. 10.1038/s42003-019-0554-8.
|
|
|
Chen, X;
Zhabyeyev, P;
Azad, AK;
Wang, W;
Minerath, RA;
DesAulniers, J;
Grueter, CE;
... Oudit, GY; + view all
(2019)
Endothelial and cardiomyocyte PI3Kβ divergently regulate cardiac remodelling in response to ischaemic injury.
Cardiovascular Research
, 115
(8)
pp. 1343-1356.
10.1093/cvr/cvy298.
|
|
Chervova, O;
Conde, L;
Guerra-Assunção, JA;
Moghul, I;
Webster, AP;
Berner, A;
Larose Cadieux, E;
... Beck, S; + view all
(2019)
The Personal Genome Project-UK, an open access resource of human multi-omics data.
Scientific Data
, 6
, Article 257. 10.1038/s41597-019-0205-4.
|
|
|
Christen, F;
Hoyer, K;
Yoshida, K;
Hou, H-A;
Waldhueter, N;
Heuser, M;
Hills, RK;
... Damm, F; + view all
(2019)
Genomic landscape and clonal evolution of acute myeloid leukemia with t(8;21): an international study on 331 patients.
Blood
, 133
(10)
pp. 1140-1151.
10.1182/blood-2018-05-852822.
|
|
Chung, HC;
Arkenau, H-T;
Lee, J;
Rha, SY;
Oh, D-Y;
Wyrwicz, L;
Kang, Y-K;
... Safran, H; + view all
(2019)
Avelumab (anti-PD-L1) as first-line switch-maintenance or second-line therapy in patients with advanced gastric or gastroesophageal junction cancer: phase 1b results from the JAVELIN Solid Tumor trial.
Journal for ImmunoTherapy of Cancer
, 7
, Article 30. 10.1186/s40425-019-0508-1.
|
|
|
Clamp, AR;
James, EC;
McNeish, IA;
Dean, A;
Kim, J-W;
O'Donnell, DM;
Hook, J;
... Ledermann, JA; + view all
(2019)
Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial.
The Lancet
10.1016/s0140-6736(19)32259-7.
|
|
|
Clarke, MA;
Fisher, J;
(2019)
Prognostic hallmarks in AML.
Nature Biomedical Engineering
, 3
(11)
pp. 847-849.
10.1038/s41551-019-0474-4.
|
|
Clarke, NW;
Ali, A;
Ingleby, FC;
Hoyle, A;
Amos, CL;
Attard, G;
Brawley, CD;
... James, ND; + view all
(2019)
Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial.
Annals of Oncology
10.1093/annonc/mdz396.
(In press).
|
|
Cohen, H;
Mackie, IJ;
Devreese, KMJ;
(2019)
Clinical and laboratory practice for lupus anticoagulant testing: An International Society of Thrombosis and Haemostasis Scientific and Standardization Committee survey.
Journal of Thrombosis and Haemostasis
, 17
(10)
pp. 1715-1732.
10.1111/jth.14560.
|
|
Cohen, OC;
Counsell, N;
Rabin, N;
Popat, R;
Owen, RG;
Popova, B;
Schofield, O;
... Yong, KL; + view all
(2019)
Bortezomib consolidation post-ASCT as frontline therapy for multiple myeloma deepens disease response and MRD-negative rate whilst maintaining QOL and response to re-treatment at relapse.
[Letter].
British Journal of Haematology
, 185
(5)
pp. 948-951.
10.1111/bjh.15649.
|
|
Coleman, RL;
Ledermann, JA;
(2019)
Maintenance treatment for recurrent ovarian carcinoma – Evidence supporting the efficacy and safety of PARP inhibitors.
[Review].
European Oncology and Haematology
, 15
(1)
pp. 29-40.
10.17925/EOH.2019.15.1.29.
|
|
Colombo, N;
Sessa, C;
du Bois, A;
Ledermann, J;
McCluggage, WG;
McNeish, I;
Morice, P;
... Zeimet, AG; + view all
(2019)
ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease.
International Journal of Gynecological Cancer
, 29
(4)
pp. 728-760.
10.1136/ijgc-2019-000308.
|
|
|
Colombo, N;
Sessa, C;
du Bois, A;
Ledermann, J;
McCluggage, WG;
McNeish, I;
Morice, P;
... ESMO–ESGO Ovarian Cancer Consensus Conference Working Group, .; + view all
(2019)
ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease.
Annals of Oncology
, 30
(5)
pp. 672-705.
10.1093/annonc/mdz062.
|
|
Conesa, A;
Beck, S;
(2019)
Making multi-omics data accessible to researchers.
[Editorial comment].
Scientific Data
, 6
(1)
, Article 251. 10.1038/s41597-019-0258-4.
|
|
|
Conteduca, V;
Jayaram, A;
Romero-Laorden, N;
Wetterskog, D;
Salvi, S;
Gurioli, G;
Scarpi, E;
... de Giorgi, U; + view all
(2019)
Plasma Androgen Receptor and Docetaxel for Metastatic Castration-resistant Prostate Cancer.
European Urology
10.1016/j.eururo.2018.09.049.
(In press).
|
|
|
Cook, G;
Royle, K-L;
O'Connor, S;
Cairns, DA;
Ashcroft, AJ;
Williams, CD;
Hockaday, A;
... National Cancer Research Institute Haemato-oncology Clinical Stu; + view all
(2019)
The impact of cytogenetics on duration of response and overall survival in patients with relapsed multiple myeloma (long-term follow-up results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial.
British Journal of Haematology
10.1111/bjh.15782.
(In press).
|
|
|
Coombes, C;
Page, K;
Salari, R;
Hastings, RK;
Armstrong, AC;
Ahmed, S;
Ali, S;
... Shaw, JA; + view all
(2019)
Personalized detection of circulating tumor DNA antedates breast cancer metastatic recurrence.
Clinical Cancer Research
, 25
(14)
pp. 4255-4263.
10.1158/1078-0432.CCR-18-3663.
|
|
Coosemans, A;
Vankerckhoven, A;
Baert, T;
Boon, L;
Ruts, H;
Riva, M;
Blagden, S;
... Vergote, I; + view all
(2019)
Combining conventional therapy with immunotherapy: A risky business?
European Journal of Cancer
, 113
pp. 41-44.
10.1016/j.ejca.2019.02.014.
|
 |
|
Coughtrey, AE;
Shafran, R;
Su, MT;
Allcott-Watson, H;
Christie, D;
Hough, R;
(2019)
Health Professionals' Perspectives on the Nature of Distress and Low Mood in Young People with Cancer.
Journal of Adolescent and Young Adult Oncology
, 8
(2)
pp. 190-196.
10.1089/jayao.2018.0082.
|
|
Creary, LE;
Guerra, SG;
Chong, W;
Brown, CJ;
Turner, TR;
Robinson, J;
Bultitude, WP;
... Fernandez-Vina, MA; + view all
(2019)
Next-generation HLA typing of 382 International Histocompatibility Working Group reference B-lymphoblastoid cell lines: Report from the 17th International HLA and Immunogenetics Workshop.
Human Immunology
, 80
(7)
pp. 449-460.
10.1016/j.humimm.2019.03.001.
|
|
Crowley, C;
Butler, C;
Camilli, C;
Hynds, R;
Kolluri, KK;
Janes, SM;
De Coppi, P;
(2019)
Non-invasive longitudinal bioluminescence imaging of human mesoangioblasts in bioengineered esophagi.
Tissue Engineering Part C: Methods
, 25
(2)
pp. 103-113.
10.1089/ten.TEC.2018.0351.
|
|
|
Cuadrado, MM;
Szydlo, RM;
Watts, M;
Patel, N;
Renshaw, H;
Dorman, J;
Lowdell, M;
... Chakraverty, R; + view all
(2019)
Predictors of recovery following allogeneic CD34+-selected cell infusion without conditioning to correct poor graft function.
Haematologica
, 105
(11)
10.3324/haematol.2019.226340.
|
|
Cuff, AO;
Sillito, F;
Dertschnig, S;
Hall, A;
Tu, VL;
Chakraverty, R;
Male, V;
(2019)
The Obese Liver Environment Mediates Conversion of NK Cells to a Less Cytotoxic ILC1-Like Phenotype.
Frontiers in Immunology
, 10
, Article 2180. 10.3389/fimmu.2019.02180.
|
|
D
|
Dagil, L;
Troelsen, KS;
Bolt, G;
Thim, L;
Wu, B;
Zhao, X;
Tuddenham, EGD;
... Hansen, DF; + view all
(2019)
Interaction Between the a3 Region of Factor VIII and the TIL'E’ Domains of the von Willebrand Factor.
Biophysical Journal
, 117
(3)
pp. 479-489.
10.1016/j.bpj.2019.07.007.
|
|
|
Das-Gupta, E;
Thomson, KJ;
Bloor, AJC;
Clark, AD;
Mackinnon, S;
Kayani, I;
Clifton-Hadley, L;
... Peggs, KS; + view all
(2019)
Allo-HSCT in transplant-naive patients with Hodgkin lymphoma: a single-arm, multicenter study.
Blood Advances
, 3
(24)
pp. 4264-4270.
10.1182/bloodadvances.2019001016.
|
|
de Boer, SM;
Powell, ME;
Mileshkin, L;
Katsaros, D;
Bessette, P;
Haie-Meder, C;
Ottevanger, PB;
... Tubiana-Mathieu, N; + view all
(2019)
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial.
The Lancet Oncology
10.1016/S1470-2045(19)30395-X.
(In press).
|
|
|
de Bono, JS;
Concin, N;
Hong, DS;
Thistlethwaite, FC;
Machiels, J-P;
Arkenau, H-T;
Plummer, R;
... Lassen, U; + view all
(2019)
Tisotumab vedotin in patients with advanced or metastatic solid tumours (InnovaTV 201): a first-in-human, multicentre, phase 1-2 trial.
Lancet Oncology
, 20
(3)
pp. 383-393.
10.1016/S1470-2045(18)30859-3.
|
|
Dehbi, H-M;
Mallick, U;
Wadsley, J;
Newbold, K;
Harmer, C;
Hackshaw, A;
(2019)
Recurrence after low-dose radioiodine ablation and recombinant human thyroid-stimulating hormone for differentiated thyroid cancer (HiLo): long-term results of an open-label, non-inferiority randomised controlled trial.
Lancet Diabetes and Endocrinology
, 7
(1)
pp. 44-51.
10.1016/S2213-8587(18)30306-1.
|
|
|
Dillon, MT;
Grove, L;
Newbold, KL;
Shaw, H;
Brown, NF;
Mendell, J;
Chen, S;
... Harrington, KJ; + view all
(2019)
Patritumab with Cetuximab plus Platinum-Containing Therapy in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: An Open-Label, Phase Ib Study.
Clinical Cancer Research
, 25
(2)
pp. 487-495.
10.1158/1078-0432.CCR-18-1539.
|
|
Dodagatta-Marri, E;
Meyer, DS;
Reeves, MQ;
Paniagua, R;
To, MD;
Binnewies, M;
Broz, ML;
... Akhurst, RJ; + view all
(2019)
α-PD-1 therapy elevates Treg/Th balance and increases tumor cell pSmad3 that are both targeted by α-TGFβ antibody to promote durable rejection and immunity in squamous cell carcinomas.
Journal for ImmunoTherapy of Cancer
, 7
, Article 62. 10.1186/s40425-018-0493-9.
|
|
|
Donald, A;
Cizer, H;
Finnegan, N;
Collin-Histed, T;
Hughes, DA;
Davies, EH;
(2019)
Measuring disease activity and patient experience remotely using wearable technology and a mobile phone app: outcomes from a pilot study in Gaucher disease.
Orphanet Journal of Rare Diseases
, 14
, Article 212. 10.1186/s13023-019-1182-6.
|
|
|
Drayson, MT;
Bowcock, S;
Planche, T;
Iqbal, G;
Pratt, G;
Yong, K;
Wood, J;
... Dunn, JA; + view all
(2019)
Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial.
The Lancet Oncology
, 20
(12)
pp. 1760-1772.
10.1016/S1470-2045(19)30506-6.
|
|
|
Drayson, MT;
Bowcock, S;
Planche, T;
Iqbal, G;
Pratt, G;
Yong, K;
Wood, J;
... Dunn, JA; + view all
(2019)
Prophylactic levofloxacin to prevent infections in newly diagnosed symptomatic myeloma: the TEAMM RCT.
Health Technology Assessment
, 23
(62)
10.3310/hta23620.
|
|
|
Dufek, S;
Cheshire, C;
Levine, AP;
Trompeter, RS;
Issler, N;
Stubbs, M;
Mozere, M;
... Bockenhauer, D; + view all
(2019)
Genetic identification of two novel loci associated with steroid-sensitive nephrotic syndrome.
Journal of the American Society of Nephrology
, 30
(8)
pp. 1375-1384.
10.1681/ASN.2018101054.
|
 |
|
Dyke, SOM;
Saulnier, KM;
Dupras, C;
Webster, AP;
Maschke, K;
Rothstein, M;
Siebert, R;
... Joly, Y; + view all
(2019)
Points-to-consider on the return of results in epigenetic research.
Genome Medicine
, 11
(1)
, Article 31. 10.1186/s13073-019-0646-6.
|
|
E
|
Ecker, S;
Beck, S;
(2019)
The epigenetic clock: a molecular crystal ball for human aging?
Aging (Albany NY)
, 11
(2)
pp. 833-835.
10.18632/aging/101712.
|
|
|
Efthymiou, M;
Mackie, IJ;
Lane, PJ;
Andrade, D;
Willis, R;
Erkan, D;
Sciascia, S;
... APS ACTION, .; + view all
(2019)
Comparison of real world and core laboratory lupus anticoagulant results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repository.
Journal of Thrombosis and Haemostasis
, 17
(12)
pp. 2069-2080.
10.1111/jth.14596.
|
|
El-Sharkawi, D;
Ng, C-H;
Payne, EMC;
Yong, KL;
Ardeshna, KM;
Khwaja, A;
Townsend, W;
(2019)
Clinical outcomes and survival of patients with myeloma and lymphoma enrolled into phase I clinical trials.
British Journal of Haematology
, 185
(2)
pp. 344-347.
10.1111/bjh.15457.
|
|
Embleton-Thirsk, A;
Deane, E;
Townsend, S;
Farrelly, L;
Popoola, B;
Parker, J;
Rustin, G;
... Kaplan, R; + view all
(2019)
Impact of retrospective data verification to prepare the ICON6 trial for use in a marketing authorization application.
Clinical Trials
, 16
(5)
pp. 502-511.
10.1177/1740774519862528.
|
|
|
Engelhardt, M;
Yong, K;
Bringhen, S;
Waesch, R;
(2019)
Carfilzomib combination treatment as first-line therapy in multiple myeloma: where do we go from the Carthadex (KTd)-trial update?
[Editorial comment].
Haematologica
, 104
(11)
pp. 2128-2131.
10.3324/haematol.2019.228684.
|
|
|
Evans, R;
Flores-Borja, F;
Nassiri, S;
Miranda, E;
Lawler, K;
Grigoriadis, A;
Monypenny, J;
... Ng, T; + view all
(2019)
Integrin-Mediated Macrophage Adhesion Promotes Lymphovascular Dissemination in Breast Cancer.
Cell Reports
, 27
(7)
1967-1978.e4.
10.1016/j.celrep.2019.04.076.
|
|
|
Evans, RDR;
Cargill, T;
Goodchild, G;
Oliveira, B;
Rodriguez-Justo, M;
Pepper, R;
Connolly, J;
... Culver, EL; + view all
(2019)
Clinical Manifestations and Long-term Outcomes of IgG4-Related Kidney and Retroperitoneal Involvement in a United Kingdom IgG4-Related Disease Cohort.
Kidney International Reports
, 4
(1)
pp. 48-58.
10.1016/j.ekir.2018.08.011.
|
|
|
Evans, REC;
Taylor, SA;
Kalasthry, J;
Sakai, NS;
Miles, A;
Streamline investigators;
(2019)
Patient deprivation and perceived scan burden negatively impact the quality of whole-body MRI.
Clinical Radiology
10.1016/j.crad.2019.10.019.
(In press).
|
|
|
Evans, TRJ;
Dean, E;
Molife, LR;
Lopez, J;
Ranson, M;
El-Khouly, F;
Zubairi, I;
... Kristeleit, R; + view all
(2019)
Phase 1 dose-finding and pharmacokinetic study of eribulin-liposomal formulation in patients with solid tumours.
British Journal of Cancer
, 120
pp. 379-386.
10.1038/s41416-019-0377-x.
|
|
|
Eyre, TA;
Kirkwood, AA;
Gohill, S;
Follows, G;
Walewska, R;
Walter, H;
Cross, M;
... the UK CLL Forum; + view all
(2019)
Efficacy of venetoclax monotherapy in patients with relapsed chronic lymphocytic leukaemia in the post-BCR inhibitor setting: a UK wide analysis.
British Journal of Haematology
, 185
(4)
pp. 656-669.
10.1111/bjh.15802.
|
|
Eyre, TA;
Kirkwood, AA;
Wolf, J;
Hildyard, C;
Mercer, C;
Plaschkes, H;
Griffith, J;
... Hatton, CSR; + view all
(2019)
Stand-alone intrathecal central nervous system (CNS) prophylaxis provide unclear benefit in reducing CNS relapse risk in elderly DLBCL patients treated with R-CHOP and is associated increased infection-related toxicity.
British Journal of Haematology
, 187
(2)
pp. 185-194.
10.1111/bjh.16070.
|
|
F
|
Fang, C;
Virdee, S;
Jacob, J;
Rufai, O;
Agarwal, K;
Quaglia, A;
Quinlan, DJ;
(2019)
Strain elastography for noninvasive assessment of liver fibrosis: A prospective study with histological comparison.
Ultrasound
, 27
(4)
pp. 262-271.
10.1177/1742271X19862836.
|
|
|
Ferrer, IR;
West, HC;
Henderson, S;
Ushakov, DS;
Santos E Sousa, P;
Strid, J;
Chakraverty, R;
... Bennett, CL; + view all
(2019)
A wave of monocytes is recruited to replenish the long-term Langerhans cell network after immune injury.
Science Immunology
, 4
(38)
, Article eaax8704. 10.1126/sciimmunol.aax8704.
|
|
|
Fielding, AK;
(2019)
Curing Ph+ ALL: assessing the relative contributions of chemotherapy, TKIs, and allogeneic stem cell transplant.
Hematology, the ASH Education Program
, 2019
(1)
pp. 24-29.
10.1182/hematology.2019000010.
|
|
Fielding, AK;
(2019)
En-Abl-ing treatment of “Ph-like” ALL?
Blood
, 134
(16)
pp. 1277-1278.
10.1182/blood.2019002621.
|
|
Fittall, MW;
Van Loo, P;
(2019)
Translating insights into tumor evolution to clinical practice: promises and challenges.
Genome Medicine
, 11
, Article 20. 10.1186/s13073-019-0632-z.
|
|
Forster, MD;
Dillon, MT;
Kocsis, J;
Remenár, É;
Pajkos, G;
Rolland, F;
Greenberg, J;
(2019)
Patritumab or placebo, with cetuximab plus platinum therapy in recurrent or metastatic squamous cell carcinoma of the head and neck: A randomised phase II study.
European Journal of Cancer
, 123
pp. 36-47.
10.1016/j.ejca.2019.08.017.
|
|
|
Fox, TA;
Carpenter, B;
Khwaja, A;
Halsey, R;
Grandage, V;
Mansour, MR;
Fielding, AK;
(2019)
Utility of FDG-PET/CT in Lymphoblastic Lymphoma.
Presented at: 61st ASH Annual Meeting, Orlando, FL, USA.
|
|
Foxall, E;
Staszowska, A;
Hirvonen, LM;
Georgouli, M;
Ciccioli, M;
Rimmer, A;
Williams, L;
... Wells, CM; + view all
(2019)
PAK4 Kinase Activity Plays a Crucial Role in the Podosome Ring of Myeloid Cells.
Cell Reports
, 29
(11)
3385-3393.e6.
10.1016/j.celrep.2019.11.016.
|
|
|
Franz Demane, Dafne Sofia;
(2019)
Defining and targeting combination immunotherapies in mouse models of cancer.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Frizziero, M;
Wang, X;
Chakrabarty, B;
Childs, A;
Luong, TV;
Walter, T;
Khan, MS;
... McNamara, MG; + view all
(2019)
Retrospective study on mixed neuroendocrine non-neuroendocrine neoplasms from five European centres.
World Journal of Gastroenterology
, 25
(39)
pp. 5991-6005.
10.3748/wjg.v25.i39.5991.
|
|
|
Fujimitsu, K;
Yamano, H;
(2019)
PP2A-B56 binds to Apc1 and promotes Cdc20 association with the APC/C ubiquitin ligase in mitosis.
EMBO Reports
, Article e48503. 10.15252/embr.201948503.
(In press).
|
|
|
Furniss, D;
Mayer, A;
Franklin, BD;
Blandford, A;
(2019)
Exploring structure, agency and performance variability in everyday safety: An ethnographic study of practices around infusion devices using distributed cognition.
Safety Science
, 118
pp. 687-701.
10.1016/j.ssci.2019.06.006.
|
|
G
|
Gaifulina, R;
Caruana, DJ;
Oukrif, D;
Guppy, NJ;
Culley, S;
Brown, R;
Bell, I;
... Thomas, GMH; + view all
(2019)
Rapid and complete paraffin removal from human tissue sections delivers enhanced Raman spectroscopic and histopathological analysis.
Analyst
10.1039/c9an01030k.
(In press).
|
|
|
Gardiner, C;
Lane, P;
Tailor, H;
Mackie, IJ;
(2019)
A practical method for reducing the interference due to lipaemia in coagulation tests.
International Journal of Laboratory Hematology
, 42
(2)
pp. 140-144.
10.1111/ijlh.13129.
|
|
|
Germain, DP;
Arad, M;
Burlina, A;
Elliott, PM;
Falissard, B;
Feldt-Rasmussen, U;
Hilz, MJ;
... Spada, M; + view all
(2019)
The effect of enzyme replacement therapy on clinical outcomes in female patients with Fabry disease - A systematic literature review by a European panel of experts.
Molecular Genetics and Metabolism
, 126
(3)
pp. 224-235.
10.1016/j.ymgme.2018.09.007.
|
|
|
Germain, DP;
Nicholls, K;
Giugliani, R;
Bichet, DG;
Hughes, DA;
Barisoni, LM;
Colvin, RB;
... Viereck, C; + view all
(2019)
Efficacy of the pharmacologic chaperone migalastat in a subset of male patients with the classic phenotype of Fabry disease and migalastat-amenable variants: data from the phase 3 randomized, multicenter, double-blind clinical trial and extension study.
Genetics in Medicine
10.1038/s41436-019-0451-z.
(In press).
|
|
|
Ghorashian, S;
Kramer, AM;
Onuoha, S;
Wright, G;
Bartram, J;
Richardson, R;
Albon, SJ;
... Amrolia, PJ; + view all
(2019)
Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR.
Nature Medicine
, 25
pp. 1408-1414.
10.1038/s41591-019-0549-5.
|
|
Glaire, MA;
Domingo, E;
Sveen, A;
Bruun, J;
Nesbakken, A;
Nicholson, G;
Novelli, M;
... Church, DN; + view all
(2019)
Tumour-infiltrating CD8^{+} lymphocytes and colorectal cancer recurrence by tumour and nodal stage.
British Journal of Cancer
, 121
pp. 474-482.
10.1038/s41416-019-0540-4.
|
|
Glaser, M;
Rajkumar, V;
Diocou, S;
Gendron, T;
Yan, R;
Sin, PKB;
Sander, K;
... Arstad, E; + view all
(2019)
One-Pot Radiosynthesis and Biological Evaluation of a Caspase-3 Selective 5-[¹²³,¹²⁵I]iodo-1,2,3-triazole derived Isatin SPECT Tracer.
Scientific Reports
, 9
, Article 19299. 10.1038/s41598-019-55992-0.
|
|
|
Gökbuget, N;
Kantarjian, HM;
Brüggemann, M;
Stein, AS;
Bargou, RC;
Dombret, H;
Fielding, AK;
... Topp, MS; + view all
(2019)
Molecular response with blinatumomab in relapsed/refractory B-cell precursor acute lymphoblastic leukemia.
Blood Advances
, 3
(20)
pp. 3033-3037.
10.1182/bloodadvances.2019000457.
|
|
|
Golan, T;
Hammel, P;
Reni, M;
Van Cutsem, E;
Macarulla, T;
Hall, MJ;
Park, J-O;
... Kindler, HL; + view all
(2019)
Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer.
The New England Journal of Medicine
, 381
pp. 317-327.
10.1056/NEJMoa1903387.
|
|
González Martín, A;
Oza, A;
Embleton, AC;
Pfisterer, J;
Ledermann, J;
Pujade-Lauraine, E;
Kristensen, G;
... Perren, T; + view all
(2019)
Exploratory outcome analyses according to stage and/or residual disease in the ICON7 trial of carboplatin and paclitaxel with or without bevacizumab for newly diagnosed ovarian cancer.
Gynecologic Oncology
, 152
(1)
10.1016/j.ygyno.2018.08.036.
|
|
|
González-Billalabeitia, E;
Conteduca, V;
Wetterskog, D;
Jayaram, A;
Attard, G;
(2019)
Circulating tumor DNA in advanced prostate cancer: transitioning from discovery to a clinically implemented test.
Prostate Cancer and Prostatic Diseases
, 22
pp. 195-205.
10.1038/s41391-018-0098-x.
|
|
Gore, M;
Hackshaw, A;
Brady, WE;
Penson, RT;
Zaino, R;
McCluggage, WG;
Ganesan, R;
... Gershenson, DM; + view all
(2019)
An international, phase III randomized trial in patients with mucinous epithelial ovarian cancer (mEOC/GOG 0241) with long-term follow-up: and experience of conducting a clinical trial in a rare gynecological tumor.
Gynecologic Oncology
, 153
(3)
pp. 541-548.
10.1016/j.ygyno.2019.03.256.
|
|
|
Goswami, P;
Oliva, EN;
Ionova, T;
Else, R;
Kell, J;
Fielding, AK;
Jennings, DM;
... Salek, S; + view all
(2019)
Paper and electronic versions of HM-PRO, a novel patient-reported outcome measure for hematology: an equivalence study.
Journal Of Comparative Effectiveness Research
, 8
(7)
pp. 523-533.
10.2217/cer-2018-0108.
|
|
|
Gourley, C;
Balmaña, J;
Ledermann, JA;
Serra, V;
Dent, R;
Loibl, S;
Pujade-Lauraine, E;
(2019)
Moving From Poly (ADP-Ribose) Polymerase Inhibition to Targeting DNA Repair and DNA Damage Response in Cancer Therapy.
Journal of Clinical Oncology
, 37
(25)
pp. 2257-2269.
10.1200/JCO.18.02050.
|
|
Granai, M;
Ambrosio, MR;
Akarca, A;
Mundo, L;
Vergoni, F;
Santi, R;
Mancini, V;
... Lazzi, S; + view all
(2019)
Role of Epstein Barr virus in transformation of follicular lymphoma to diffuse large B-cell lymphoma: a case report and review of the literature.
Haematologica
10.3324/haematol.2018.215053.
|
|
|
Greenwood, HE;
McCormick, PN;
Gendron, T;
Glaser, M;
Pereira, R;
Maddocks, ODK;
Sander, K;
... Witney, TH; + view all
(2019)
Measurement of Tumor Antioxidant Capacity and Prediction of Chemotherapy Resistance in Preclinical Models of Ovarian Cancer by Positron Emission Tomography.
Clinical Cancer Research
, 25
(8)
pp. 2471-2482.
10.1158/1078-0432.CCR-18-3423.
|
|
Gupta, RK;
Abdul-Jawad, S;
McCoy, LE;
Mok, HP;
Peppa, D;
Salgado, M;
Martinez-Picado, J;
... Olavarria, E; + view all
(2019)
HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation.
Nature
, 568
pp. 244-249.
10.1038/s41586-019-1027-4.
|
H
|
Hagos, YB;
Narayanan, PL;
Akarca, AU;
Marafioti, T;
Yuan, Y;
(2019)
ConCORDe-net: Cell count regularized convolutional neural network for cell detection in multiplex immunohistochemistry images.
In:
Medical Image Computing and Computer Assisted Intervention – MICCAI 2019.
(pp. pp. 667-675).
Springer: Shenzhen, China.
|
|
|
Hainsworth, Emma Georgina;
(2019)
HIV positive and treated for cancer: the social context and lived experiences of dual diagnosis and its treatment.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Hamilton, N;
Hynds, R;
Gowers, K;
Tait, A;
Butler, C;
Hopper, C;
Burns, A;
... Janes, SM; + view all
(2019)
Using a 3D collagen matrix to deliver respiratory progenitor cells to decellularized trachea in vivo.
Tissue Engineering Part C: Methods
, 25
(2)
pp. 93-102.
10.1089/ten.TEC.2018.0241.
|
|
Hammel, P;
Kindler, HL;
Reni, M;
Van Cutsem, E;
Macarulla, T;
Hall, MJ;
Park, JO;
... Golan, T; + view all
(2019)
Health-related quality of life in patients with a germline BRCA mutation and metastatic pancreatic cancer receiving maintenance olaparib.
Annals of Oncology
10.1093/annonc/mdz406.
(In press).
|
|
|
Han, G;
Berhane, S;
Toyoda, H;
Bettinger, D;
Elshaarawy, O;
Chan, AWH;
Kirstein, M;
... Johnson, PJ; + view all
(2019)
Prediction of Survival Among Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma: A Response-Based Approach.
Hepatology
10.1002/hep.31022.
(In press).
|
|
|
Handle, F;
Prekovic, S;
Helsen, C;
Van den Broeck, T;
Smeets, E;
Moris, L;
Eerlings, R;
... Claessens, F; + view all
(2019)
Drivers of AR indifferent anti-androgen resistance in prostate cancer cells.
Scientific Reports
, 9
, Article 137. 10.1038/s41598-019-50220-1.
|
|
|
Henninger, B;
Alustiza, J;
Garbowski, M;
Gandon, Y;
(2019)
Practical guide to quantification of hepatic iron with MRI.
European Radiology
10.1007/s00330-019-06380-9.
|
|
|
Henry, Jake Yarren;
(2019)
Innate lymphoid-macrophage crosstalk promotes lung cancer regression in response to IL-12 therapy.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
|
Hofvander, J;
Puls, F;
Pillay, N;
Steele, CD;
Flanagan, AM;
Magnusson, L;
Nilsson, J;
(2019)
Undifferentiated pleomorphic sarcomas with PRDM10 fusions have a distinct gene expression profile.
The Journal of Pathology
, 249
(4)
pp. 425-434.
10.1002/path.5326.
|
|
Hoskin, PJ;
Hopkins, K;
Misra, V;
Holt, T;
McMenemin, R;
Dubois, D;
McKinna, F;
... Lopes, A; + view all
(2019)
Effect of Single-Fraction vs Multifraction Radiotherapy on Ambulatory Status Among Patients With Spinal Canal Compression From Metastatic Cancer: The SCORAD Randomized Clinical Trial.
JAMA
, 322
(21)
pp. 2084-2094.
10.1001/jama.2019.17913.
|
|
Hostettler, IC;
Bernal-Quiros, M;
Wong, A;
Sharma, N;
Wilson, D;
Seiffge, D;
Shakeshaft, C;
... Houlden, H; + view all
(2019)
C9orf72 and intracerebral haemorrhage.
Neurobiology of Aging
, 84
237.e1-237.e3.
10.1016/j.neurobiolaging.2019.07.007.
|
|
Howard, J;
Hemmaway, CJ;
Telfer, P;
Layton, DM;
Porter, J;
Awogbade, M;
Mant, T;
... Lehrer-Graiwer, J; + view all
(2019)
A phase 1/2 ascending dose study and open-label extension study of voxelotor in patients with sickle cell disease.
Blood
, 133
(17)
pp. 1865-1875.
10.1182/blood-2018-08-868893.
|
|
Hoyle, AP;
Ali, A;
James, ND;
Cook, A;
Parker, CC;
de Bono, JS;
Attard, G;
... STAMPEDE Investigators; + view all
(2019)
Abiraterone in "High-" and "Low-risk" Metastatic Hormone-sensitive Prostate Cancer.
European Urology
, 76
(6)
pp. 719-728.
10.1016/j.eururo.2019.08.006.
|
|
Hu, X;
Fujimoto, J;
Ying, L;
Fukuoka, J;
Ashizawa, K;
Sun, W;
Reuben, A;
... Zhang, J; + view all
(2019)
Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma.
Nature Communications
, 10
, Article 2978. 10.1038/s41467-019-10877-8.
|
|
|
Huettenhain, R;
Choi, M;
de la Fuente, LM;
Oehl, K;
Chang, C-YV;
Zimmermann, A-K;
Malander, S;
... Aebersold, R; + view all
(2019)
A Targeted Mass Spectrometry Strategy for Developing Proteomic Biomarkers: A Case Study of Epithelial Ovarian Cancer.
Molecular & Cellular Proteomics
, 18
(9)
pp. 1836-1850.
10.1074/mcp.RA118.001221.
|
|
|
Hughes, D;
Mikosch, P;
Belmatoug, N;
Carubbi, F;
Cox, T;
Goker-Alpan, O;
Kindmark, A;
... Deegan, P; + view all
(2019)
Gaucher Disease in Bone: From Pathophysiology to Practice.
Journal of Bone and Mineral Research
, 34
(6)
pp. 996-1013.
10.1002/jbmr.3734.
|
|
|
Hughes, DA;
Nicholls, K;
Sunder-Plassmann, G;
Jovanovic, A;
Feldt-Rasmussen, U;
Schiffmann, R;
Giugliani, R;
... Bichet, DG; + view all
(2019)
Safety of switching to Migalastat from enzyme replacement therapy in Fabry disease: Experience from the Phase 3 ATTRACT study.
American Journal of Medical Genetics: Part A
10.1002/ajmg.a.61105.
(In press).
|
|
|
Hutchison, IL;
Ridout, F;
Cheung, SMY;
Shah, N;
Hardee, P;
Surwald, C;
Thiruchelvam, J;
... Hackshaw, A; + view all
(2019)
Nationwide randomised trial evaluating elective neck dissection for early stage oral cancer (SEND study) with meta-analysis and concurrent real-world cohort.
British Journal of Cancer
10.1038/s41416-019-0587-2.
(In press).
|
|
I
|
Ilson, DH;
Tabernero, J;
Prokharau, A;
Arkenau, H-T;
Ghidini, M;
Fujitani, K;
Van Cutsem, E;
... Shitara, K; + view all
(2019)
Efficacy and Safety of Trifluridine/Tipiracil Treatment in Patients With Metastatic Gastric Cancer Who Had Undergone Gastrectomy: Subgroup Analyses of a Randomized Clinical Trial.
JAMA Oncology
, 6
(1)
, Article e193531.. 10.1001/jamaoncol.2019.3531.
|
|
|
Ismail, Mazlina;
(2019)
Computational analysis of T cell receptor repertoires in health and disease.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Iveson, T;
Boyd, KA;
Kerr, RS;
Robles-Zurita, J;
Saunders, MP;
Briggs, AH;
Cassidy, J;
... Paul, J; + view all
(2019)
3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT.
Health Technology Assessment
, 23
(64)
pp. 1-88.
10.3310/hta23640.
|
|
J
|
Joharatnam-Hogan, N;
Cafferty, F;
Hubner, R;
Swinson, D;
Sothi, S;
Gupta, K;
Falk, S;
... Add-Aspirin Trial Management Group; + view all
(2019)
Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial.
The Lancet Gastroenterology & Hepatology
, 4
(11)
pp. 854-862.
10.1016/S2468-1253(19)30289-4.
|
|
Johnson, SP;
Ogunlade, O;
Lythgoe, MF;
Beard, P;
Pedley, RB;
(2019)
Longitudinal Photoacoustic Imaging of the Pharmacodynamic Effect of Vascular Targeted Therapy on Tumors.
Clinical Cancer Research
, 25
(24)
pp. 7436-7447.
10.1158/1078-0432.CCR-19-0360.
|
|
Johnston, EW;
Bonet-Carne, E;
Ferizi, U;
Yvernault, B;
Pye, H;
Patel, D;
Clemente, J;
... Punwani, S; + view all
(2019)
VERDICT MRI for Prostate Cancer: Intracellular Volume Fraction versus Apparent Diffusion Coefficient.
Radiology
, 291
(2)
pp. 391-397.
10.1148/radiol.2019181749.
|
|
Johnstone, R;
Atkinson, D;
Chouhan, M;
Sharma, R;
McClelland, J;
(2019)
Free-breathing MRI of the upper abdomen assisted by motion modelling.
In:
Proceedings of the ISMRM 27th Annual Meeting & Exhibition.
International Society for Magnetic Resonance in Medicine (ISMRM): Montréal, Canada.
|
|
Jones, GG;
Del Río, IB;
Sari, S;
Sekerim, A;
Young, LC;
Hartig, N;
Areso Zubiaur, I;
... Rodriguez-Viciana, P; + view all
(2019)
SHOC2 phosphatase-dependent RAF dimerization mediates resistance to MEK inhibition in RAS-mutant cancers.
Nature Communications
, 10
(1)
, Article 2532. 10.1038/s41467-019-10367-x.
|
|
|
Jones, RL;
Ratain, MJ;
O'Dwyer, PJ;
Siu, LL;
Jassem, J;
Medioni, J;
DeJonge, M;
... Schwartz, G; + view all
(2019)
Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours.
European Journal of Cancer
, 120
pp. 132-139.
10.1016/j.ejca.2019.07.024.
|
|
|
Jones, RP;
Psarelli, E-E;
Jackson, R;
Ghaneh, P;
Halloran, CM;
Palmer, DH;
Campbell, F;
... European Study Group for Pancreatic Cancer, .; + view all
(2019)
Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Secondary Analysis of the ESPAC-4 Randomized Adjuvant Chemotherapy Trial.
JAMA Surgery
10.1001/jamasurg.2019.3337.
(In press).
|
|
Joshi, K;
Robert de Massy, M;
Ismail, M;
Reading, JL;
Uddin, I;
Woolston, A;
Hatipoglu, E;
... Chain, B; + view all
(2019)
Spatial heterogeneity of the T cell receptor repertoire reflects the mutational landscape in lung cancer.
Nature Medicine
, 25
pp. 1549-1559.
10.1038/s41591-019-0592-2.
|
K
|
Kataria, M;
Yamano, H;
(2019)
Interplay between Phosphatases and the Anaphase-Promoting Complex/Cyclosome in Mitosis.
MDPI — Cells
, 8
(8)
, Article 814. 10.3390/cells8080814.
|
|
|
Kenten, C;
Ngwenya, N;
Gibson, F;
Flatley, M;
Jones, L;
Pearce, S;
Wong, G;
... Whelan, J; + view all
(2019)
Understanding care when cure is not likely for young adults who face cancer: a realist analysis of data from patients, families and healthcare professionals.
BMJ Open
, 9
(1)
, Article e024397. 10.1136/bmjopen-2018-024397.
|
|
|
Kidd, AC;
Skrzypski, M;
Jamal-Hanjani, M;
Blyth, KG;
(2019)
Cancer cachexia in thoracic malignancy: a narrative review.
Current Opinion in Supportive and Palliative Care
, 13
(4)
pp. 316-322.
10.1097/SPC.0000000000000465.
|
|
Kim, M;
Torrealdea, F;
Adeleke, O;
Rega, M;
Evans, V;
Beeston, T;
Soteriou, K;
... Golay, X; + view all
(2019)
Challenges in glucoCEST MR body imaging at 3 Tesla.
Quantitative Imaging in Medicine and Surgery
, 9
(10)
pp. 1628-1640.
10.21037/qims.2019.10.05.
|
|
|
Kim, RD;
Sarker, D;
Meyer, T;
Yau, T;
Macarulla, T;
Park, J-W;
Choo, SP;
... Kang, Y-K; + view all
(2019)
First-in-Human Phase I Study of Fisogatinib (BLU-554) Validates Aberrant Fibroblast Growth Factor 19 Signaling as a Driver Event in Hepatocellular Carcinoma.
Cancer Discovery
, 9
(12)
pp. 1696-1707.
10.1158/2159-8290.CD-19-0555.
|
|
Kleftogiannis, D;
Punta, M;
Jayaram, A;
Sandhu, S;
Wong, SQ;
Gasi Tandefelt, D;
Conteduca, V;
... Lise, S; + view all
(2019)
Identification of single nucleotide variants using position-specific error estimation in deep sequencing data.
BMC Med Genomics
, 12
(1)
, Article 115. 10.1186/s12920-019-0557-9.
|
|
|
Knott, KD;
Augusto, JB;
Nordin, S;
Kozor, R;
Camaioni, C;
Xue, H;
Hughes, RK;
... Moon, JC; + view all
(2019)
Quantitative Myocardial Perfusion in Fabry Disease.
Circulation: Cardiovascular Imaging
, 12
(7)
, Article e008872. 10.1161/CIRCIMAGING.119.008872.
|
|
Kolovos, S;
Nador, G;
Kishore, B;
Streetly, M;
Rabin, NK;
Chantry, AD;
Yong, K;
... Pinedo-Villanueva, R; + view all
(2019)
Unplanned admissions for patients with myeloma in the UK: Low frequency but high costs.
Journal of Bone Oncology
, 17
, Article 100243. 10.1016/j.jbo.2019.100243.
|
|
|
Koonyosying, P;
Uthaipibull, C;
Fucharoen, S;
Koumoutsea, EV;
Porter, JB;
Srichairatanakool, S;
(2019)
Decrement in Cellular Iron and Reactive Oxygen Species, and Improvement of Insulin Secretion in a Pancreatic Cell Line Using Green Tea Extract.
Pancreas
, 48
(5)
pp. 636-643.
10.1097/MPA.0000000000001320.
|
|
|
Kopetz, S;
Grothey, A;
Yaeger, R;
Van Cutsem, E;
Desai, J;
Yoshino, T;
Wasan, H;
... Tabernero, J; + view all
(2019)
Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer.
The New England Journal of Medicine
, 381
(17)
pp. 1632-1643.
10.1056/NEJMoa1908075.
|
|
Kosmin, M;
Ledsam, J;
Romera-Paredes, B;
Mendes, R;
Moinuddin, S;
de Souza, D;
Gunn, L;
... Sharma, RA; + view all
(2019)
Rapid advances in auto-segmentation of organs at risk and target volumes in head and neck cancer.
Radiotherapy and Oncology
, 135
pp. 130-140.
10.1016/j.radonc.2019.03.004.
|
|
Kreuzaler, P;
Clarke, MA;
Brown, EJ;
Wilson, CH;
Kortlever, RM;
Piterman, N;
Littlewood, T;
... Fisher, J; + view all
(2019)
Heterogeneity of Myc expression in breast cancer exposes pharmacological vulnerabilities revealed through executable mechanistic modeling.
Proceedings of the National Academy of Sciences
, 116
(44)
pp. 22399-22408.
10.1073/pnas.1903485116.
|
|
Krishna-Subramanian, S;
Singer, S;
Armaka, M;
Banales, JM;
Holzer, K;
Schirmacher, P;
Walczak, H;
... Kondylis, V; + view all
(2019)
RIPK1 and death receptor signaling drive biliary damage and early liver tumorigenesis in mice with chronic hepatobiliary injury.
Cell Death & Differentiation
10.1038/s41418-019-0330-9.
(In press).
|
|
Kristeleit, RS;
Oaknin, A;
Ray-Coquard, I;
Leary, A;
Balmaña, J;
Drew, Y;
Oza, AM;
... McNeish, IA; + view all
(2019)
Antitumor activity of the poly(ADP-ribose) polymerase inhibitor rucaparib as monotherapy in patients with platinum-sensitive, relapsed, BRCA-mutated, high-grade ovarian cancer, and an update on safety.
International Journal of Gynecological Cancer
, 29
(9)
pp. 1396-1404.
10.1136/ijgc-2019-000623.
|
|
|
Kular, L;
Needhamsen, M;
Adzemovic, MZ;
Kramarova, T;
Gomez-Cabrero, D;
Ewing, E;
Piket, E;
... Jagodic, M; + view all
(2019)
Neuronal methylome reveals CREB-associated neuro-axonal impairment in multiple sclerosis.
Clinical Epigenetics
, 11
(1)
, Article 86. 10.1186/s13148-019-0678-1.
|
|
Kumar, N;
Alfrifai, D;
Kolluri, KK;
Sage, EK;
Ishii, Y;
Guppy, N;
Borg, E;
... Janes, SM; + view all
(2019)
Retrospective response analysis of BAP1 expression to predict the clinical activity of systemic cytotoxic chemotherapy in mesothelioma.
Lung Cancer
, 127
pp. 164-166.
10.1016/j.lungcan.2018.12.004.
|
L
|
Lancia, C;
Anninga, J;
Spitoni, C;
Sydes, MR;
Whelan, J;
Hogendoorn, PCW;
Gelderblom, H;
(2019)
Method to measure the mismatch between target and achieved received dose intensity of chemotherapy in cancer trials: a retrospective analysis of the MRC BO06 trial in osteosarcoma.
BMJ Open
, 9
(5)
, Article e022980. 10.1136/bmjopen-2018-022980.
|
|
|
Lancia, C;
Anninga, JK;
Sydes, M;
Spitoni, C;
Whelan, J;
Hogendoorn, PCW;
Gelderblom, H;
(2019)
A novel method to address the association between received dose intensity and survival outcome: benefits of approaching treatment intensification at a more individualised level in a trial of the European Osteosarcoma Intergroup.
Cancer Chemotherapy and Pharmacology
10.1007/s00280-019-03797-3.
(In press).
|
|
|
Latifoltojar, A;
Punwani, S;
Lopes, A;
Humphries, PD;
Klusmann, M;
Menezes, LJ;
Daw, S;
... Taylor, SA; + view all
(2019)
Whole-body MRI for staging and interim response monitoring
in paediatric and adolescent Hodgkin's lymphoma: a comparison
with multi-modality reference standard including 18F-FDG-PET-CT.
European Radiology
, 29
(1)
pp. 202-212.
10.1007/s00330-018-5445-8.
|
|
|
Le Quellec, S;
Dane, A;
Enjolras, N;
McIntosh, J;
Rosales, C;
Negrier, C;
Nathwani, A;
(2019)
Potential limits of AAV-based gene therapy with the use of new transgenes expressing factor IX fusion proteins.
Haemophilia
, 25
(1)
E11-E18.
10.1111/hae.13651.
|
|
Lebossé, F;
Gudd, C;
Tunc, E;
Singanayagam, A;
Nathwani, R;
Triantafyllou, E;
Pop, O;
... Khamri, W; + view all
(2019)
CD8+ T cells from patients with cirrhosis display a phenotype that may contribute to cirrhosis-associated immune dysfunction.
EBioMedicine
, 49
pp. 258-268.
10.1016/j.ebiom.2019.10.011.
|
|
|
Lechner, M;
Breeze, CE;
O'Mahony, JF;
Masterson, L;
(2019)
Early detection of HPV-associated oropharyngeal cancer.
[Letter].
Lancet
, 393
(10186)
p. 2123.
10.1016/S0140-6736(19)30227-2.
|
|
Lechner, M;
Jones, OS;
Breeze, CE;
Gilson, R;
(2019)
Gender-neutral HPV vaccination in the UK, rising male oropharyngeal cancer rates, and lack of HPV awareness.
[Letter].
Lancet Infectious Diseases
, 19
(2)
pp. 131-132.
10.1016/S1473-3099(18)30802-8.
|
|
Ledermann, JA;
(2019)
Do increased tumor infiltrating lymphocytes co-existing with Homologous Recombination Deficiency provide clues to enhance immunotherapy of ovarian cancer?
[Editorial comment].
Gynecologic Oncology
, 153
(2)
pp. 213-214.
10.1016/j.ygyno.2019.04.014.
|
|
Ledermann, JA;
(2019)
Extending the scope of PARP inhibitors in ovarian cancer.
[Editorial comment].
The Lancet Oncology
, 20
(4)
pp. 470-472.
10.1016/S1470-2045(19)30019-1.
|
|
Ledermann, JA;
Pujade-Lauraine, E;
(2019)
Olaparib as maintenance treatment for patients with platinum-sensitive relapsed ovarian cancer.
Therapeutic Advances in Medical Oncology
, 11
pp. 1-18.
10.1177/1758835919849753.
|
|
|
Lee, DDH;
Petris, A;
Hynds, RE;
O'Callaghan, C;
(2019)
Ciliated Epithelial Cell Differentiation at Air-Liquid Interface Using Commercially Available Culture Media.
Methods in Molecular Biology
, 2109
pp. 275-291.
10.1007/7651_2019_269.
|
|
Lee, SM;
Upadhyay, S;
Lewanski, C;
Falk, S;
Skailes, G;
Woll, PJ;
Hatton, M;
... Hackshaw, A; + view all
(2019)
The clinical role of VeriStrat testing in patients with advanced non-small cell lung cancer considered unfit for first-line platinum-based chemotherapy.
European Journal of Cancer
, 120
pp. 86-96.
10.1016/j.ejca.2019.07.025.
|
|
|
Leija-Salazar, M;
Sedlazeck, FJ;
Toffoli, M;
Mullin, S;
Mokretar, K;
Athanasopoulou, M;
Donald, A;
... Proukakis, C; + view all
(2019)
Evaluation of the detection of GBA missense mutations and other variants using the Oxford Nanopore MinION.
Molecular Genetics & Genomic Medicine
10.1002/mgg3.564.
(In press).
|
|
Lin, CC;
Arkenau, HT;
Lu, S;
Sachdev, J;
de Castro Carpeño, J;
Mita, M;
Dziadziuszko, R;
... Weiss, GJ; + view all
(2019)
A phase 1, open-label, dose-escalation trial of oral TSR-011 in patients with advanced solid tumours and lymphomas.
British Journal of Cancer
, 121
pp. 131-138.
10.1038/s41416-019-0503-9.
|
|
|
Ling, Gavin Chien Pang;
(2019)
Use of bispecific single chain variable fragments in haemophilia A gene therapy.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
|
Livanos, Maria;
(2019)
Production of DARPins in the Yeast Pichia pastoris.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Loveday, C;
Sud, A;
Litchfield, K;
Levy, M;
Holroyd, A;
Broderick, P;
Kote-Jarai, Z;
... Turnbull, C; + view all
(2019)
Runs of homozygosity and testicular cancer risk.
Andrology
, 7
(4)
pp. 555-564.
10.1111/andr.12667.
|
|
Luxton, HJ;
Simpson, BS;
Mills, IG;
Brindle, NR;
Ahmed, Z;
Stavrinides, V;
Heavey, S;
... Whitaker, HC; + view all
(2019)
The Oncogene Metadherin Interacts with the Known Splicing Proteins YTHDC1, Sam68 and T-STAR and Plays a Novel Role in Alternative mRNA Splicing.
Cancers
, 11
(9)
, Article 1233. 10.3390/cancers11091233.
|
|
|
Ly, P;
Brunner, SF;
Shoshani, O;
Kim, DH;
Lan, W;
Pyntikova, T;
Flanagan, AM;
... Cleveland, DW; + view all
(2019)
Chromosome segregation errors generate a diverse spectrum of simple and complex genomic rearrangements.
Nature Genetics
, 51
(4)
pp. 705-715.
10.1038/s41588-019-0360-8.
|
|
M
|
Macklin, PS;
Pillay, N;
Lee, JL;
Pitman, H;
Scott, S;
Wang, J;
Craig, C;
... Williams, D-A; + view all
(2019)
CM-Path Molecular Diagnostics Forum-consensus statement on the development and implementation of molecular diagnostic tests in the United Kingdom.
British Journal of Cancer volume
, 121
(9)
pp. 738-743.
10.1038/s41416-019-0588-1.
|
|
Madsen, RR;
Knox, RG;
Pearce, W;
Lopez, S;
Mahler-Araujo, B;
McGranahan, N;
Vanhaesebroeck, B;
(2019)
Oncogenic PIK3CA promotes cellular stemness in an allele dose-dependent manner.
Proceedings of the National Academy of Sciences of The United States of America
10.1073/pnas.1821093116.
(In press).
|
|
|
Maggio, V;
Canovas, V;
Felix, AJ;
Gomez, V;
de Torres, I;
Eugenia Semidey, M;
Morote, J;
... Paciucci, R; + view all
(2019)
A novel DNA-binding motif in prostate tumor overexpressed-1 (PTOV1) required for the expression of ALDH1A1 and CCNG2 in cancer cells.
Cancer Letters
, 452
pp. 158-167.
10.1016/j.canlet.2019.03.019.
|
|
|
Mahmud-Al-Rafat, A;
Majumder, A;
Rahman, KMT;
Hasan, AMM;
Islam, KMD;
Taylor-Robinson, AW;
Billah, MM;
(2019)
Decoding the enigma of antiviral crisis: Does one target molecule regulate all?
Cytokine
, 115
pp. 13-23.
10.1016/j.cyto.2018.12.008.
|
|
|
Mak, G;
Soria, J-C;
Blagden, SP;
Plummer, R;
Fleming, RA;
Nebot, N;
Zhang, J;
... Arkenau, H-T; + view all
(2019)
A phase Ib dose-finding, pharmacokinetic study of the focal adhesion kinase inhibitor GSK2256098 and trametinib in patients with advanced solid tumours.
British Journal of Cancer
(120)
pp. 975-981.
10.1038/s41416-019-0452-3.
|
|
|
Manwani, R;
Mahmood, S;
Sachchithanantham, S;
Lachmann, HJ;
Gillmore, JD;
Yong, K;
Rabin, N;
... Wechalekar, AD; + view all
(2019)
Carfilzomib is an effective upfront treatment in AL amyloidosis patients with peripheral and autonomic neuropathy.
British Journal of Haematology
, 187
(5)
pp. 638-641.
10.1111/bjh.16122.
|
|
Marioni, RE;
Suderman, M;
Chen, BH;
Horvath, S;
Bandinelli, S;
Morris, T;
Beck, S;
... Hägg, S; + view all
(2019)
Tracking the Epigenetic Clock Across the Human Life Course: A Meta-analysis of Longitudinal Cohort Data.
The Journals of Gerontology: Series A
, 74
(1)
pp. 57-61.
10.1093/gerona/gly060.
|
|
|
Martinez, V;
Pankova, V;
Krasney, L;
Singh, T;
White, I;
Benjamin, A;
dertsching, S;
... Acton, S; + view all
(2019)
Conduit integrity is compromised during acute lymph node expansion.
BioRxiv: Cold Spring Harbor, NY, USA.
|
|
Martinez, VG;
Pankova, V;
Krasny, L;
Singh, T;
Makris, S;
White, IJ;
Benjamin, AC;
... Acton, SE; + view all
(2019)
Fibroblastic Reticular Cells Control Conduit Matrix Deposition during Lymph Node Expansion.
Cell Reports
, 29
(9)
2810-2822.e5.
10.1016/j.celrep.2019.10.103.
|
|
|
Martínez-Mármol, R;
Mohannak, N;
Qian, L;
Wang, T;
Gormal, RS;
Ruitenberg, MJ;
Vanhaesebroeck, B;
... Meunier, FA; + view all
(2019)
p110δ PI 3-kinase inhibition perturbs APP and TNFα trafficking, reduces plaque burden, dampens neuroinflammation and prevents cognitive decline in an Alzheimer's disease mouse model.
The Journal of Neuroscience
, 39
(40)
pp. 7976-7991.
10.1523/JNEUROSCI.0674-19.2019.
|
|
Marzolini, Maria Ann Veronica;
(2019)
The characterisation and manipulation of a novel subset of tumour-reactive CD4+ cytotoxic T lymphocytes in human cancer.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Marzolini, MAV;
Jaunmuktane, Z;
Roddie, C;
O'Reilly, M;
Chiodini, P;
Peggs, KS;
(2019)
Toxoplasmosis initially presenting as neurological sequelae of chimeric antigen receptor T-cell therapy.
The Lancet Infectious Diseases
, 19
(7)
p. 788.
10.1016/S1473-3099(19)30119-7.
|
|
|
Marzvanyan, A;
Alhawaj, AF;
(2019)
Physiology, Sensory Receptors.
StatPearls Publishing
|
|
Mateos, M-V;
Ludwig, H;
Bazarbachi, A;
Beksac, M;
Bladé, J;
Boccadoro, M;
Cavo, M;
... Sonneveld, P; + view all
(2019)
Insights on Multiple Myeloma Treatment Strategies.
HemaSphere
, 3
(1)
, Article e163. 10.1097/HS9.0000000000000163.
|
|
|
Mato, AR;
Roeker, LE;
Eyre, TA;
Nabhan, C;
Lamanna, N;
Hill, BT;
Brander, DM;
... Fox, CP; + view all
(2019)
A retrospective comparison of venetoclax alone or in combination with an anti-CD20 monoclonal antibody in R/R CLL.
Blood Advances
, 3
(10)
pp. 1568-1573.
10.1182/bloodadvances.2019000180.
|
|
|
Matulonis, UA;
Shapira-Frommer, R;
Santin, AD;
Lisyanskaya, AS;
Pignata, S;
Vergote, I;
Raspagliesi, F;
... Ledermann, JA; + view all
(2019)
Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study.
Annals of Oncology
, 30
(7)
pp. 1080-1087.
10.1093/annonc/mdz135.
|
|
Matulonis, UA;
Walder, L;
Nøttrup, TJ;
Bessette, P;
Mahner, S;
Gil-Martin, M;
Kalbacher, E;
... Mirza, MR; + view all
(2019)
Niraparib Maintenance Treatment Improves Time Without Symptoms or Toxicity (TWiST) Versus Routine Surveillance in Recurrent Ovarian Cancer: A TWiST Analysis of the ENGOT-OV16/NOVA Trial.
Journal of Clinical Oncology
, 37
(34)
pp. 3183-3191.
10.1200/JCO.19.00917.
|
|
|
Mawer, S;
Alhawaj, AF;
(2019)
Physiology, Defecation.
StatPearls Publishing
|
|
Mayor, NP;
Hayhurst, JD;
Turner, TR;
Szydlo, RM;
Shaw, BE;
Bultitude, WP;
Sayno, J-R;
... Marsh, SGE; + view all
(2019)
Recipients Receiving Better HLA-Matched Hematopoietic Cell Transplantation Grafts, Uncovered by a Novel HLA Typing Method, Have Superior Survival: A Retrospective Study.
Biology of Blood and Marrow Transplantation
, 25
(3)
pp. 443-450.
10.1016/j.bbmt.2018.12.768.
|
|
|
McCormick, PN;
Greenwood, HE;
Glaser, M;
Maddocks, ODK;
Gendron, T;
Sander, K;
Gowrishankar, G;
... Witney, TH; + view all
(2019)
Assessment of tumor redox status through (S)-4-(3-[18F]fluoropropyl)-L-glutamic acid positron emission tomography imaging of system xc- activity.
Cancer Research
, 79
(4)
pp. 853-863.
10.1158/0008-5472.CAN-18-2634.
|
|
McDonnell, T;
Wincup, C;
Buchholz, I;
Pericleous, C;
Giles, I;
Ripoll, V;
Cohen, H;
... Rahman, A; + view all
(2019)
The role of beta-2-glycoprotein I in health and disease associating structure with function: More than just APS.
Blood Reviews
, Article 100610. 10.1016/j.blre.2019.100610.
|
|
|
McGranahan, N;
Swanton, C;
(2019)
Neoantigen quality, not quantity.
Science Translational Medicine
, 11
(506)
, Article eaax7918. 10.1126/scitranslmed.aax7918.
|
|
|
McLean, BA;
Patel, VB;
Zhabyeyev, P;
Chen, X;
Basu, R;
Wang, F;
Shah, S;
... Oudit, GY; + view all
(2019)
PI3Kα Pathway Inhibition With Doxorubicin Treatment Results in Distinct Biventricular Atrophy and Remodeling With Right Ventricular Dysfunction.
Journal of the American Heart Association
, 8
(9)
, Article e010961. 10.1161/JAHA.118.010961.
|
|
|
Mehta, A;
Kuter, DJ;
Salek, SS;
Belmatoug, N;
Bembi, B;
Bright, J;
vom Dahl, S;
... Zimran, A; + view all
(2019)
Presenting signs and patient co-variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED-C) Delphi initiative.
Internal Medicine Journal
, 49
(5)
pp. 578-591.
10.1111/imj.14156.
|
|
|
Meijles, DN;
Zoumpoulidou, G;
Markou, T;
Rostron, KA;
Patel, R;
Lay, K;
Handa, BS;
... Clerk, A; + view all
(2019)
The cardiomyocyte “redox rheostat”: Redox signalling via the AMPK-mTOR axis and regulation of gene and protein expression balancing survival and death.
Journal of Molecular and Cellular Cardiology
, 129
pp. 118-129.
10.1016/j.yjmcc.2019.02.006.
|
|
Mekkaoui, L;
Ferrari, M;
Mattiuzzo, G;
Ma, B;
Nannini, F;
Onuoha, S;
Kotsopoulou, E;
... Pule, M; + view all
(2019)
Generation of a neutralizing antibody against RD114-pseudotyped viral vectors.
Journal of General Virology
10.1099/jgv.0.001309.
(In press).
|
|
|
Menares, E;
Gálvez-Cancino, F;
Cáceres-Morgado, P;
Ghorani, E;
López, E;
Díaz, X;
Saavedra-Almarza, J;
... Lladser, A; + view all
(2019)
Tissue-resident memory CD8⁺ T cells amplify anti-tumor immunity by triggering antigen spreading through dendritic cells.
Nature Communications
, 10
(1)
, Article 4401. 10.1038/s41467-019-12319-x.
|
|
Meric-Bernstam, F;
Hurwitz, H;
Raghav, KPS;
McWilliams, RR;
Fakih, M;
VanderWalde, A;
Swanton, C;
... Hainsworth, J; + view all
(2019)
Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study.
Lancet Oncology
, 20
(4)
pp. 518-530.
10.1016/S1470-2045(18)30904-5.
|
|
Messaoudene, M;
Mourikis, TP;
Michels, J;
Fu, Y;
Bonvalet, M;
Lacroix-Trikki, M;
Routy, B;
... Zitvogel, L; + view all
(2019)
T-cell bispecific antibodies in node-positive breast cancer: novel therapeutic avenue for MHC class I loss variants.
Annals of Oncology
, 30
(6)
pp. 934-944.
10.1093/annonc/mdz112.
|
|
Miles, A;
Bhatnagar, G;
Halligan, S;
Gupta, A;
Tolan, D;
Zealley, I;
Taylor, SA;
(2019)
Magnetic resonance enterography, small bowel ultrasound and colonoscopy to diagnose and stage Crohn's disease: patient acceptability and perceived burden.
European Radiology
, 29
(3)
pp. 1083-1093.
10.1007/s00330-018-5661-2.
|
|
|
Miles, A;
Taylor, SA;
Evans, REC;
Halligan, S;
Beare, S;
Bridgewater, J;
Goh, V;
... Yu, D; + view all
(2019)
Patient preferences for whole-body MRI or conventional staging pathways in lung and colorectal cancer: a discrete choice experiment.
European Radiology
, 29
(7)
pp. 3889-3900.
10.1007/s00330-019-06153-4.
|
|
|
Miller, RE;
Crusz, SM;
Ledermann, JA;
(2019)
Olaparib maintenance for first-line treatment of ovarian cancer: will SOLO1 reset the standard of care?
Future Oncology
, 15
(16)
pp. 1845-1853.
10.2217/fon-2019-0057.
|
|
Mohty, M;
Cavo, M;
Fink, L;
Gonzalez-McQuire, S;
Leleu, H;
Mateos, M-V;
Raab, MS;
... Yong, K; + view all
(2019)
Understanding mortality in multiple myeloma: Findings of a European retrospective chart review.
European Journal of Haematology
, 103
(2)
pp. 107-115.
10.1111/ejh.13264.
|
|
|
Moore, A;
Kane, E;
Wang, Z;
Panagiotou, OA;
Teras, LR;
Monnereau, A;
Wong Doo, N;
... Berndt, SI; + view all
(2019)
Genetically Determined Height and Risk of Non-hodgkin Lymphoma.
Frontiers in Oncology
, 9
, Article 1539. 10.3389/fonc.2019.01539.
|
|
|
Moore, DA;
Kushnir, M;
Mak, G;
Winter, H;
Curiel, T;
Voskoboynik, M;
Moschetta, M;
... Arkenau, HT; + view all
(2019)
Prospective analysis of 895 patients on a UK Genomics Review Board.
ESMO Open
, 4
(2)
, Article e000469. 10.1136/esmoopen-2018-000469.
|
|
|
Moore, DA;
Sereno, M;
Das, M;
Baena Acevedo, JD;
Sinnadurai, S;
Smith, C;
McSweeney, A;
... Le Quesne, J; + view all
(2019)
In situ growth in early lung adenocarcinoma may represent precursor growth or invasive clone outgrowth-a clinically relevant distinction.
Modern Pathology
10.1038/s41379-019-0257-1.
(In press).
|
|
Morris, EC;
Tendeiro-Rego, R;
Richardson, R;
Fox, TA;
Sillito, F;
Holler, A;
Thomas, S;
... Stauss, H; + view all
(2019)
A Phase I Study Evaluating the Safety and Persistence of Allorestricted WT1-TCR Gene Modified Autologous T Cells in Patients with High-Risk Myeloid Malignancies Unsuitable for Allogeneic Stem Cell Transplantation.
Presented at: 61st ASH Annual Meeting, Orlando, FL, USA.
|
|
Mott, CE;
Ng, K;
Alifrangis, C;
(2019)
The management of patients with learning difficulties and testicular cancer: overcoming barriers to improve care.
BMJ Case Reports
, 12
(11)
, Article e227330. 10.1136/bcr-2018-227330.
|
|
|
Mourikis, TP;
Benedetti, L;
Foxall, E;
Temelkovski, D;
Nulsen, J;
Perner, J;
Cereda, M;
... Ciccarelli, FD; + view all
(2019)
Patient-specific cancer genes contribute to recurrently perturbed pathways and establish therapeutic vulnerabilities in esophageal adenocarcinoma.
Nature Communications
, 10
(1)
, Article 3101. 10.1038/s41467-019-10898-3.
|
|
|
Mullin, S;
Beavan, M;
Bestwick, J;
McNeill, A;
Proukakis, C;
Cox, T;
Hughes, D;
... Schapira, AHV; + view all
(2019)
Evolution and clustering of prodromal parkinsonian features in GBA1 carriers.
Movement Disorders
, 34
(9)
pp. 1365-1373.
10.1002/mds.27775.
|
|
N
|
Naumann, RW;
Hollebecque, A;
Meyer, T;
Devlin, M-J;
Oaknin, A;
Kerger, J;
López-Picazo, JM;
... Moore, KN; + view all
(2019)
Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial.
Journal of Clinical Oncology
, 37
(31)
pp. 2825-2834.
10.1200/JCO.19.00739.
|
|
Newton, C;
Murali, K;
Ahmad, A;
Hockings, H;
Graham, R;
Liberale, V;
Sarker, S-J;
... Lockley, M; + view all
(2019)
A multicentre retrospective cohort study of ovarian germ cell tumours: Evidence for chemotherapy de-escalation and alignment of paediatric and adult practice.
European Journal of Cancer
, 113
pp. 19-27.
10.1016/j.ejca.2019.03.001.
|
|
|
Nguyen, HP;
Stewart, S;
Kukwikila, MN;
Jones, SF;
Offenbartl-Stiegert, D;
Mao, S;
Balasubramanian, S;
... Howorka, S; + view all
(2019)
A Photo‐responsive Small‐Molecule Approach for the Opto‐epigenetic Modulation of DNA Methylation.
Angewandte Chemie: International Edition
, 58
(20)
pp. 6620-6624.
10.1002/anie.201901139.
|
|
Nieuwenburg, SAV;
Waddingham, WW;
Graham, D;
Rodriguez-Justo, M;
Biermann, K;
Kuipers, EJ;
Banks, M;
... Spaander, MCW; + view all
(2019)
Accuracy of endoscopic staging and targeted biopsies for routine gastric intestinal metaplasia and gastric atrophy evaluation study protocol of a prospective, cohort study: the estimate study.
BMJ Open
, 9
(9)
, Article e032013. 10.1136/bmjopen-2019-032013.
|
|
|
Nordin, S;
Kozor, R;
Vijapurapu, R;
Augusto, JB;
Knott, KD;
Captur, G;
Treibel, TA;
... Moon, JC; + view all
(2019)
Myocardial Storage, Inflammation, and Cardiac Phenotype in Fabry Disease After One Year of Enzyme Replacement Therapy.
Circulation: Cardiovascular Imaging
, 12
(12)
, Article e009430. 10.1161/CIRCIMAGING.119.009430.
|
|
O
|
O'Reilly, MA;
Govender, D;
Kirkwood, AA;
Vora, A;
Samarasinghe, S;
Khwaja, A;
Grandage, V;
... O'Connor, D; + view all
(2019)
The incidence of invasive fungal infections in children, adolescents and young adults with acute lymphoblastic leukaemia/lymphoma treated with the UKALL2011 protocol: a multicentre retrospective study.
[Letter].
British Journal of Haematology
, 186
(2)
pp. 327-329.
10.1111/bjh.15798.
|
|
Ogunlade, O;
Ho, J;
Kalber, T;
Hynds, R;
Zhang, E;
Janes, SM;
Birchall, M;
... Beard, P; + view all
(2019)
Monitoring neovascularization and integration of decellularized human scaffolds using photoacoustic imaging.
Photoacoustics
, 13
pp. 76-84.
10.1016/j.pacs.2019.01.001.
(In press).
|
|
|
Ometto, G;
Moghul, I;
Montesano, G;
Hunter, A;
Pontikos, N;
Jones, P;
Keane, P;
... Crabb, D; + view all
(2019)
ReLayer: a free, online tool for extracting retinal thickness from cross-platform OCT images.
Translational Vision Science and Technology
, 8
(3)
, Article 25. 10.1167/tvst.8.3.25.
|
|
|
Ovcinnikovs, V;
Ross, EM;
Petersone, L;
Edner, NM;
Heuts, F;
Ntavli, E;
Kogimtzis, A;
... Walker, LSK; + view all
(2019)
CTLA-4-mediated transendocytosis of costimulatory molecules primarily targets migratory dendritic cells.
Science Immunology
, 4
(35)
, Article eaaw0902. 10.1126/sciimmunol.aaw0902.
|
P
|
Pantaleo, MA;
Tarantino, G;
Agostinelli, C;
Urbini, M;
Nannini, M;
Saponara, M;
Castelli, C;
... Astolfi, A; + view all
(2019)
Immune microenvironment profiling of gastrointestinal stromal tumors (GIST) shows gene expression patterns associated to immune checkpoint inhibitors response.
OncoImmunology
10.1080/2162402X.2019.1617588.
|
|
|
Parry, MA;
Srivastava, S;
Ali, A;
Cannistraci, A;
Antonello, J;
Barros-Silva, JD;
Ubertini, V;
... Baena, E; + view all
(2019)
Genomic Evaluation of Multiparametric Magnetic Resonance Imaging-visible and -nonvisible Lesions in Clinically Localised Prostate Cancer.
European Urology Oncology
, 2
(1)
pp. 1-11.
10.1016/j.euo.2018.08.005.
|
|
|
Paz, K;
Flynn, R;
Du, J;
Tannheimer, S;
Johnson, AJ;
Dong, S;
Stark, A-K;
... Blazar, BR; + view all
(2019)
Targeting PI3Kδ function for amelioration of murine chronic graft‐versus‐host disease.
American Journal of Transplantation
, 19
(6)
pp. 1820-1830.
10.1111/ajt.15305.
|
|
Peltzer, N;
Walczak, H;
(2019)
Cell Death and Inflammation - A Vital but Dangerous Liaison.
Trends in Immunology
, 40
(5)
pp. 387-402.
10.1016/j.it.2019.03.006.
|
|
Peltzer, N;
Walczak, H;
(2019)
Endothelial Cell Killing by TAK1 Inhibition: A Novel Anti-angiogenic Strategy in Cancer Therapy.
Developmental Cell
, 48
(2)
pp. 127-128.
10.1016/j.devcel.2019.01.011.
|
|
Pereira, R;
Gendron, T;
Sanghera, C;
Greenwood, HE;
Newcombe, J;
McCormick, P;
Sander, K;
... Witney, TH; + view all
(2019)
Mapping Aldehyde Dehydrogenase 1A1 Activity using an [¹⁸F]Substrate-based Approach.
Chemistry & A European Journal
, 25
(9)
pp. 2345-2351.
10.1002/chem.201805473.
|
|
|
Phillips, EH;
Lannon, M;
Lopes, A;
Chadwick, H;
Jones, G;
Sieniawski, M;
Davies, A;
... Lennard, A; + view all
(2019)
High-dose chemotherapy and autologous stem cell transplantation in enteropathy-associated and other aggressive T-cell lymphomas: a UK NCRI/Cancer Research UK Phase II Study.
[Letter].
Bone Marrow Transplantation
, 54
pp. 465-468.
10.1038/s41409-018-0294-2.
|
|
Pinato, DJ;
Mauri, FA;
Spina, P;
Cain, O;
Siddique, A;
Goldin, R;
Victor, S;
... Sharma, R; + view all
(2019)
Clinical implications of heterogeneity in PD-L1 immunohistochemical detection in hepatocellular carcinoma: the Blueprint-HCC study.
British Journal of Cancer
, 120
(12)
pp. 1033-1036.
10.1038/s41416-019-0466-x.
|
|
|
Plesner, T;
Arkenau, HT;
Gay, F;
Minnema, MC;
Boccadoro, M;
Moreau, P;
Cavenagh, J;
... Richardson, PG; + view all
(2019)
Enduring efficacy and tolerability of daratumumab in combination with lenalidomide and dexamethasone in patients with relapsed or relapsed/refractory multiple myeloma (GEN503): final results of an open-label, phase 1/2 study.
British Journal of Haematology
, 186
(3)
e35-e39.
10.1111/bjh.15879.
|
|
Popat, R;
Brown, SR;
Flanagan, L;
Hall, A;
Gregory, W;
Kishore, B;
Streetly, M;
... Cavenagh, J; + view all
(2019)
Extended follow‐up and the feasibility of Panobinostat maintenance for patients with Relapsed Multiple Myeloma treated with Bortezomib, Thalidomide, Dexamethasone plus Panobinostat (MUK six open label, multi‐centre phase I/II Clinical Trial).
British Journal of Haematology
, 185
(3)
pp. 573-578.
10.1111/bjh.15551.
|
|
Powles, T;
Kockx, M;
Rodriguez-Vida, A;
Duran, I;
Crabb, SJ;
Van Der Heijden, MS;
Szabados, B;
... Castellano, D; + view all
(2019)
Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial.
Nature Medicine
, 25
(11)
pp. 1706-1714.
10.1038/s41591-019-0628-7.
|
|
|
Primrose, JN;
Fox, RP;
Palmer, DH;
Malik, HZ;
Prasad, R;
Mirza, D;
Anthony, A;
... Bridgewater, J; + view all
(2019)
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study.
Lancet Oncology
, 20
(5)
pp. 663-673.
10.1016/S1470-2045(18)30915-X.
|
|
Priyann, A;
Woodcroft, BJ;
Rai, V;
Moghul, I;
Munagala, A;
Ter, F;
Chowdhary, H;
... Wurm, Y; + view all
(2019)
Sequenceserver: A Modern Graphical User Interface for Custom BLAST Databases.
Molecular Biology and Evolution
, 36
(12)
pp. 2922-2924.
10.1093/molbev/msz185.
|
|
|
Proctor, Toby Joseph;
(2019)
Translational process engineering for tissue engineered hollow organ advanced therapy investigational medicinal products.
Doctoral thesis (Eng.D), UCL (University College London).
|
|
Pugh, G;
Hough, R;
Gravestock, H;
Davies, C;
Horder, R;
Fisher, A;
(2019)
The development and user evaluation of health behaviour change resources for teenage and young adult Cancer survivors.
Research Involvement and Engagement
, 5
, Article 9. 10.1186/s40900-019-0142-6.
|
|
|
Pugh, G;
Hough, R;
Gravestock, H;
Fisher, A;
(2019)
The health behaviour status of teenage and young adult cancer patients and survivors in the United Kingdom.
Support Care Cancer
10.1007/s00520-019-04719-y.
(In press).
|
|
|
Pugh, G;
Hough, R;
Hubbard, G;
Banks, E;
Fisher, A;
(2019)
Sun exposure among teenage and young adult cancer survivors in the United Kingdom.
Pediatric Blood & Cancer
, 66
(1)
, Article e27424. 10.1002/pbc.27424.
|
|
Puls, F;
Pillay, N;
Fagman, H;
Palin-Masreliez, A;
Amary, F;
Hansson, M;
Kindblom, L-G;
... Mertens, F; + view all
(2019)
PRDM10-rearranged Soft Tissue Tumor A Clinicopathologic Study of 9 Cases.
The American Journal of Surgical Pathology
, 43
(4)
pp. 504-513.
10.1097/PAS.0000000000001207.
|
Q
|
Qayyum, MS;
Hayat, H;
Matharu, RK;
Tabish, TA;
Edirisinghe, M;
(2019)
Boron nitride nanoscrolls: Structure, synthesis, and applications.
Applied Physics Reviews
, 6
(2)
, Article 021310. 10.1063/1.5092547.
|
|
Qin, Xiao;
Sufi, Jahangir;
Vlckova, Petra;
Kyriakidou, Pelagia;
Acton, Sophie;
Li, Vivian;
Nitz, Mark;
(2019)
Single-Cell Signalling Analysis of Heterocellular Organoids.
BioRxiv: Cold Spring Harbor, NY, USA.
|
|
|
Qin, S;
Finn, RS;
Kudo, M;
Meyer, T;
Vogel, A;
Ducreux, M;
Macarulla, TM;
... Zhu, AX; + view all
(2019)
RATIONALE 301 study: tislelizumab versus sorafenib as first-line treatment for unresectable hepatocellular carcinoma.
Future Oncology
, 15
(16)
pp. 1811-1822.
10.2217/fon-2019-0097.
|
|
R
|
Raab, MS;
Fink, L;
Schoen, P;
Gonzalez-McQuire, S;
Flinois, A;
Cavo, M;
Mateos, M-V;
(2019)
Evolution of multiple myeloma treatment practices in Europe from 2014 to 2016.
British Journal of Haematology
, 185
(5)
pp. 981-984.
10.1111/bjh.15680.
|
|
Radin, M;
Sciascia, S;
Erkan, D;
Pengo, V;
Tektonidou, MG;
Ugarte, A;
Meroni, P;
... APS ACTION; + view all
(2019)
The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort.
Seminars in Arthritis and Rheumatism
, 49
(3)
pp. 464-468.
10.1016/j.semarthrit.2019.04.009.
|
|
Rahman, B;
Lanceley, A;
Kristeleit, R;
Ledermann, J;
Lockley, M;
McCormack, M;
Mould, T;
(2019)
Mainstreamed genetic testing for women with ovarian cancer: first-year experience.
Journal of Medical Genetics
, 56
(3)
pp. 195-198.
10.1136/jmedgenet-2017-105140.
|
|
Rahman, S;
Mansour, MR;
(2019)
The role of noncoding mutations in blood cancers.
Disease Models & Mechanisms
, 12
(11)
, Article dmm041988. 10.1242/dmm.041988.
|
|
|
Ramage, JK;
Punia, P;
Faluyi, O;
Frilling, A;
Meyer, T;
Saharan, R;
Valle, JW;
(2019)
Observational Study to Assess Quality of Life in Patients with Pancreatic Neuroendocrine Tumors Receiving Treatment with Everolimus: The OBLIQUE Study (UK Phase IV Trial).
Neuroendocrinology
, 108
(4)
pp. 317-327.
10.1159/000497330.
|
|
Ramirez, GA;
Efthymiou, M;
Isenberg, DA;
Cohen, H;
(2019)
Under crossfire: thromboembolic risk in systemic lupus erythematosus.
Rheumatology
, 58
(6)
pp. 940-952.
10.1093/rheumatology/key307.
|
|
Ray-Coquard, I;
Trama, A;
Seckl, MJ;
Fotopoulou, C;
Pautier, P;
Pignata, S;
Kristensen, G;
... RARECARENet Working Group, .; + view all
(2019)
Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network setting.
European Journal of Surgical Oncology
, 45
(1)
pp. 67-74.
10.1016/j.ejso.2017.09.025.
|
|
Raza, SEA;
AbdulJabbar, K;
Jamal-Hanjani, M;
Veeriah, S;
Le Quesne, J;
Swanton, C;
Yuan, Y;
(2019)
Deconvolving Convolutional Neural Network for Cell Detection.
In:
2019 IEEE 16th International Symposium on Biomedical Imaging (ISBI 2019).
(pp. pp. 891-894).
IEEE: Venice, Italy,.
|
|
|
Recino, A;
Gan, SU;
Sia, KC;
Sawyer, Y;
Trendell, J;
Kay, R;
Gribble, FM;
... Wallberg, M; + view all
(2019)
Immunosuppression overcomes insulin- and vector-specific immune responses that limit efficacy of AAV2/8-mediated insulin gene therapy in NOD mice.
Gene Therapy
, 26
pp. 40-56.
10.1038/s41434-018-0052-5.
|
|
|
Reed-Berendt, R;
Shafran, R;
Langdon, D;
Christie, D;
Hough, R;
Coughtrey, A;
(2019)
Experiences of Low Mood in Young People With Cancer: A Qualitative Study.
Journal of Pediatric Oncology Nursing
10.1177/1043454219844232.
(In press).
|
|
|
Rego, RT;
Morris, EC;
Lowdell, MW;
(2019)
T-cell receptor gene-modified cells: past promises, present methodologies and future challenges.
Cytotherapy
, 21
(3)
pp. 341-357.
10.1016/j.jcyt.2018.12.002.
|
|
Rhodes, CJ;
Batai, K;
Bleda, M;
Haimel, M;
Southgate, L;
Germain, M;
Pauciulo, MW;
... Winslow, C; + view all
(2019)
Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis.
The Lancet Respiratory Medicine
, 7
(3)
pp. 227-238.
10.1016/S2213-2600(18)30409-0.
|
|
|
Richardson, S;
Brian, D;
Grandage, V;
Hough, R;
Kottaridis, P;
Mansour, M;
Payne, EMC;
(2019)
Intensive Chemotherapy Is Associated With Poor Overall Survival in Autoimmune Disease-associated Myeloid Malignancies.
HemaSphere
, 3
(1)
, Article e164. 10.1097/HS9.0000000000000164.
|
|
|
Rizzo, FM;
Vesely, C;
Childs, A;
Marafioti, T;
Khan, MS;
Mandair, D;
Cives, M;
... Meyer, T; + view all
(2019)
Circulating tumour cells and their association with bone metastases in patients with neuroendocrine tumours.
British Journal of Cancer
, 120
(3)
pp. 294-300.
10.1038/s41416-018-0367-4.
|
|
Roddie, C;
O'Reilly, M;
Dias Alves Pinto, J;
Vispute, K;
Lowdell, M;
(2019)
Manufacturing chimeric antigen receptor T cells: issues and challenges.
Cytotherapy
, 21
(3)
pp. 327-340.
10.1016/j.jcyt.2018.11.009.
|
|
Rooshenas, L;
Scott, LJ;
Blazeby, JM;
Rogers, CA;
Tilling, KM;
Husbands, S;
Conefrey, C;
... Wheatley, T; + view all
(2019)
The QuinteT Recruitment Intervention supported five randomized trials to recruit to target: a mixed-methods evaluation.
Journal of Clinical Epidemiology
, 106
pp. 108-120.
10.1016/j.jclinepi.2018.10.004.
|
|
Ros-Soto, J;
Snowden, JA;
Salooja, N;
Gilleece, M;
Parker, A;
Greenfield, DM;
Anthias, C;
... Transplant Complications Working Party of the EBMT; + view all
(2019)
Current Practice in Vitamin D Management in Allogeneic Hematopoietic Stem Cell Transplantation: A Survey by the Transplant Complications Working Party of the European Society for Blood and Marrow Transplantation.
Biology of Blood and Marrow Transplantation
, 25
(10)
pp. 2079-2085.
10.1016/j.bbmt.2019.06.015.
|
|
Rosenthal, R;
Cadieux, EL;
Salgado, R;
Bakir, MA;
Moore, DA;
Hiley, CT;
Lund, T;
... TRACERx consortium; + view all
(2019)
Neoantigen-directed immune escape in lung cancer evolution.
Nature
10.1038/s41586-019-1032-7.
(In press).
|
|
Rule, S;
Cook, G;
Russell, NH;
Hunter, A;
Robinson, S;
Morley, N;
Sureda, A;
... Peggs, KS; + view all
(2019)
Allogeneic stem cell transplantation as part of front line therapy for Mantle cell lymphoma.
British Journal of Haematology
, 184
(6)
pp. 999-1005.
10.1111/bjh.15723.
|
|
Russell, SJ;
Babovic-Vuksanovic, D;
Bexon, A;
Cattaneo, R;
Dingli, D;
Dispenzieri, A;
Deyle, DR;
... Peng, K-W; + view all
(2019)
Oncolytic Measles Virotherapy and Opposition to Measles Vaccination.
Mayo Clinic Proceedings
, 94
(9)
pp. 1834-1839.
10.1016/j.mayocp.2019.05.006.
|
|
Ryan, SG;
Butler, MN;
Adeyemi, SS;
Kalber, T;
Patrick, PS;
Zaw Thin, M;
Harrison, IF;
... Lythgoe, MF; + view all
(2019)
Imaging of X-Ray-Excited Emissions from Quantum Dots and Biological Tissue in Whole Mouse.
Scientific Reports
, 9
, Article 19223. 10.1038/s41598-019-55769-5.
|
|
S
|
Sabry, M;
Zubiak, A;
Hood, SP;
Simmonds, P;
Arellano-Ballestero, H;
Cournoyer, E;
Mashar, M;
... Lowdell, MW; + view all
(2019)
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures.
PLoS One
, 14
(6)
, Article e0218674. 10.1371/journal.pone.0218674.
|
|
|
Saint, M;
Bertaux, F;
Tang, W;
Sun, X-M;
Game, L;
Köferle, A;
Bähler, J;
... Marguerat, S; + view all
(2019)
Single-cell imaging and RNA sequencing reveal patterns of gene expression heterogeneity during fission yeast growth and adaptation.
Nature Microbiology
, 4
(3)
pp. 480-491.
10.1038/s41564-018-0330-4.
|
|
Sammaraiee, Y;
Banerjee, G;
Farmer, S;
Hylton, B;
Cowley, P;
Eleftheriou, P;
Porter, J;
(2019)
Risks associated with oral deferiprone in the treatment of infratentorial superficial siderosis.
Journal of Neurology
, 267
, Article 682. 10.1007/s00415-019-09577-6.
|
|
Saulnier, KM;
Bujold, D;
Dyke, SOM;
Dupras, C;
Beck, S;
Bourque, G;
Joly, Y;
(2019)
Benefits and barriers in the design of harmonized access agreements for international data sharing.
Scientific Data
, 6
, Article 297. 10.1038/s41597-019-0310-4.
|
|
|
Schiavone, F;
Bathia, R;
Letchmanan, K;
Masters, L;
Amos, C;
Bara, A;
Brown, L;
... Sydes, MR; + view all
(2019)
This is a platform alteration: a trial management perspective on the operational aspects of adaptive and platform and umbrella protocols.
Trials
, 20
, Article 264. 10.1186/s13063-019-3216-8.
|
|
Schiffmann, R;
Goker-Alpan, O;
Holida, M;
Giraldo, P;
Barisoni, L;
Colvin, RB;
Jennette, CJ;
... Hughes, D; + view all
(2019)
Pegunigalsidase alfa, a novel PEGylated enzyme replacement therapy for Fabry disease, provides sustained plasma concentrations and favorable pharmacodynamics: A 1-year Phase 1/2 clinical trial.
Journal of Inherited Metabolic Disease
, 42
(3)
pp. 534-544.
10.1002/jimd.12080.
|
|
|
Schols, S;
Nunn, MA;
Mackie, I;
Weston-Davies, W;
Nishimura, J-I;
Kanakura, Y;
Blijlevens, N;
... Langemeijer, S; + view all
(2019)
Successful treatment of a PNH patient non-responsive to eculizumab with the novel complement C5 inhibitor coversin (nomacopan).
British Journal of Haematology
, 188
(2)
pp. 334-337.
10.1111/bjh.16305.
|
|
Sciascia, S;
Willis, R;
Pengo, V;
Krilis, S;
Andrade, D;
Tektonidou, MG;
Ugarte, A;
... APS ACTION, .; + view all
(2019)
The comparison of real world and core laboratory antiphospholipid antibody ELISA results from antiphospholipid syndrome alliance for clinical trials & international networking (APS ACTION) clinical database and repository analysis.
Thrombosis Research
, 175
pp. 32-36.
10.1016/j.thromres.2019.01.010.
|
|
Sellar, RS;
Mehra, V;
Fox, TA;
Grigg, A;
Kulasekararaj, A;
Sarma, A;
de Lavallade, H;
... Potter, VT; + view all
(2019)
Comparative analysis of melphalan versus busulphan T-cell deplete conditioning using alemtuzumab in unrelated donor stem cell transplantation for acute myeloid leukaemia.
British Journal of Haematology
, 187
(1)
e20-e24.
10.1111/bjh.16136.
|
|
Shah, MA;
Kojima, T;
Hochhauser, D;
Enzinger, P;
Raimbourg, J;
Hollebecque, A;
Lordick, F;
... Kato, K; + view all
(2019)
Efficacy and Safety of Pembrolizumab for Heavily Pretreated Patients With Advanced, Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus. The Phase 2 KEYNOTE-180 Study.
JAMA Oncology
, 5
(4)
pp. 546-550.
10.1001/jamaoncol.2018.5441.
|
|
Shah, R;
Sabir, S;
Alhawaj, AF;
(2019)
Physiology, Breast Milk.
StatPearls Publishing
|
|
Sharif, H;
Singh, I;
Kouser, L;
Mösges, R;
Bonny, M-A;
Karamani, A;
Parkin, RV;
... Shamji, MH; + view all
(2019)
Immunologic Mechanisms of Short-course of Lolium Perenne Peptide Immunotherapy: A Randomized Double-Blind Placebo-Controlled Trial.
Journal of Allergy and Clinical Immunology
, 144
(3)
pp. 738-749.
10.1016/j.jaci.2019.02.023.
|
|
Shevtsov, M;
Stangl, S;
Nikolaev, B;
Yakovleva, L;
Marchenko, Y;
Tagaeva, R;
Sievert, W;
... Multhoff, G; + view all
(2019)
Granzyme B Functionalized Nanoparticles Targeting Membrane Hsp70‐Positive Tumors for Multimodal Cancer Theranostics.
Small
, 15
(13)
, Article 1900205. 10.1002/smll.201900205.
|
|
Singh, AN;
Oehler, J;
Torrecilla, I;
Kilgas, S;
Li, S;
Vaz, B;
Guérillon, C;
... Ramadan, K; + view all
(2019)
The p97-Ataxin 3 complex regulates homeostasis of the DNA damage response E3 ubiquitin ligase RNF8.
The EMBO Journal
, 38
(21)
, Article e102361. 10.15252/embj.2019102361.
|
|
|
Smeland, S;
Ingleby, F;
Many other authors, TPUTP;
Whelan, J;
Sydes, MR;
(2019)
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 cohort.
European Journal of Cancer
, 109
pp. 36-50.
10.1016/j.ejca.2018.11.027.
|
|
|
Spiro, SG;
Shah, PL;
Rintoul, RC;
George, J;
Janes, S;
Callister, M;
Novelli, M;
... Hackshaw, A; + view all
(2019)
Sequential screening for lung cancer in a high-risk group: randomised controlled trial.
European Respiratory Journal
, 54
(4)
, Article 1900581. 10.1183/13993003.00581-2019.
|
|
Spit, M;
Rieser, E;
Walczak, H;
(2019)
Linear ubiquitination at a glance.
Journal of Cell Science
, 132
(2)
, Article jcs208512. 10.1242/jcs.208512.
|
|
Stasi, C;
Tsochatzis, EA;
Hall, A;
Rosenberg, W;
Milani, S;
Dhillon, AP;
Pinzani, M;
(2019)
Comparison and correlation of fibrosis stage assessment by collagen proportionate area (CPA) and the ELF panel in patients with chronic liver disease.
Digestive and Liver Disease
, 51
(7)
pp. 1001-1007.
10.1016/j.dld.2018.12.005.
|
|
Steele, CD;
Tarabichi, M;
Oukrif, D;
Webster, AP;
Ye, H;
Fittall, M;
Lombard, P;
... Pillay, N; + view all
(2019)
Undifferentiated Sarcomas Develop through Distinct Evolutionary Pathways.
Cancer Cell
, 35
(3)
441-456.e8.
10.1016/j.ccell.2019.02.002.
|
|
|
Stefano, P;
Ivana, M;
Arianna, G;
Letizia, Z;
Angelo, G;
Rosella, C;
Roberta, B;
... Andrea, G; + view all
(2019)
Identification of microRNAs and relative target genes in Moringa oleifera leaf and callus.
Scientific Reports
, 9
, Article 15145. 10.1038/s41598-019-51100-4.
|
|
|
Stein, A;
Dalton, L;
Rapa, E;
Bluebond-Langner, M;
Hanington, L;
Stein, KF;
Ziebland, S;
... Yousafzai, A; + view all
(2019)
Communication with children and adolescents about the diagnosis of their own life-threatening condition.
The Lancet
, 393
(10176)
pp. 1150-1163.
10.1016/S0140-6736(18)33201-X.
|
|
Stowe, CL;
Burley, TA;
Allan, H;
Vinci, M;
Kramer-Marek, G;
Ciobota, DM;
Parkinson, GN;
... Pule, MA; + view all
(2019)
Near-infrared dual bioluminescence imaging in mouse models of cancer using infraluciferin.
eLife
, 8
, Article e45801. 10.7554/eLife.45801.
(In press).
|
|
|
Strasser, S;
Abou-Alfa, G;
Mollon, P;
Meyer, T;
Cheng, A;
El-Khoueiry, A;
Kelley, R;
... Freemantle, N; + view all
(2019)
Quality-adjusted life-years accrued with cabozantinib in patients with advanced hepatocellular carcinoma in the CELESTIAL trial.
Presented at: Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) “The Universe Within”, Adelaide, Australia.
|
|
Strauss, VY;
Shaw, R;
Virdee, PS;
Hurt, CN;
Ward, E;
Tranter, B;
Patel, N;
... Mukherjee, S; + view all
(2019)
Study protocol: a multi-centre randomised study of induction chemotherapy followed by capecitabine ± nelfinavir with high- or standard-dose radiotherapy for locally advanced pancreatic cancer (SCALOP-2).
BMC Cancer
, 19
, Article 121. 10.1186/s12885-019-5307-z.
|
|
|
Suzuki, E;
Bridgewater, J;
(2019)
Adjuvant therapy for resected gallbladder cancer.
Chinese Clinical Oncology
, 8
(4)
, Article 39. 10.21037/cco.2019.07.02.
|
|
T
|
Taher, AT;
Origa, R;
Perrotta, S;
Kouraklis, A;
Belhoul, K;
Huang, V;
Han, J;
... Porter, JB; + view all
(2019)
Influence of patient-reported outcomes on the treatment effect of deferasirox film-coated and dispersible tablet formulations in the ECLIPSE trial: A post hoc mediation analysis.
[Letter].
American Journal of Hematology
, 94
(4)
E96-E99.
10.1002/ajh.25408.
|
|
Taher, AT;
Weber, S;
Han, J;
Bruederle, A;
Porter, JB;
(2019)
Predicting serum ferritin levels in patients with iron overload treated with the film-coated tablet of deferasirox during the ECLIPSE study.
American Journal of Hematology
, 94
(1)
E15-E17.
10.1002/ajh.25322.
|
|
|
Tan, WS;
Teo, CH;
Chan, D;
Heinrich, M;
Feber, A;
Sarpong, R;
Allan, J;
... DETECT II trial collaborators; + view all
(2019)
Mix methods approach to explore patients' perspectives on the acceptability of a urinary biomarker test in replacement of cystoscopy in bladder cancer surveillance.
BJU International
, 124
(3)
pp. 408-417.
10.1111/bju.14690.
|
|
|
Taylor, A;
Vendramin, C;
Oosterholt, S;
Della Pasqua, O;
Scully, M;
(2019)
Pharmacokinetics of plasma infusion in congenital thrombotic thrombocytopenic purpura.
Journal of Thrombosis and Haemostasis
, 17
(1)
pp. 88-98.
10.1111/jth.14345.
|
|
Taylor, RM;
Fern, LA;
Barber, J;
Alvarez-Galvez, J;
Feltbower, R;
Morris, S;
Hooker, L;
... Whelan, JS; + view all
(2019)
Description of the BRIGHTLIGHT cohort: the evaluation of teenage and young adult cancer services in England.
BMJ Open
, 9
(4)
, Article e027797. 10.1136/bmjopen-2018-027797.
|
|
|
Taylor, SA;
Mallett, S;
Ball, S;
Beare, S;
Bhatnagar, G;
Bhowmik, A;
Boavida, P;
... Streamline investigators; + view all
(2019)
Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer: the prospective Streamline L trial.
Lancet Respiratory Medicine
10.1016/S2213-2600(19)30090-6.
(In press).
|
|
|
Taylor, SA;
Mallett, S;
Beare, S;
Bhatnagar, G;
Blunt, D;
Boavida, P;
Bridgewater, J;
... Streamline investigators; + view all
(2019)
Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer: the prospective Streamline C trial.
The Lancet Gastroenterology & Hepatology
, 4
(7)
pp. 529-537.
10.1016/S2468-1253(19)30056-1.
|
|
|
Taylor, SA;
Mallett, S;
Bhatnagar, G;
Morris, S;
Quinn, L;
Tomini, F;
Miles, A;
... Halligan, S; + view all
(2019)
Magnetic resonance enterography compared with ultrasonography in newly diagnosed and relapsing Crohn's disease patients: the METRIC diagnostic accuracy study.
Health Technol Assess
, 23
(42)
pp. 1-161.
10.3310/hta23420.
|
|
|
Taylor, SA;
Mallett, S;
Miles, A;
Morris, S;
Quinn, L;
Clarke, CS;
Beare, S;
... Halligan, S; + view all
(2019)
Whole-body MRI compared with standard pathways for staging metastatic disease in lung and colorectal cancer: the Streamline diagnostic accuracy studies.
Health Technology Assessment
, 23
(66)
10.3310/hta23660.
|
|
|
Teixeira, VH;
Pipinikas, CP;
Pennycuick, A;
Lee-Six, H;
Chandrasekharan, D;
Beane, J;
Morris, TJ;
... Janes, SM; + view all
(2019)
Deciphering the genomic, epigenomic, and transcriptomic landscapes of pre-invasive lung cancer lesions.
Nature Medicine
, 25
pp. 517-525.
10.1038/s41591-018-0323-0.
|
|
Tombal, B;
Saad, F;
Penson, D;
Hussain, M;
Sternberg, CN;
Morlock, R;
Ramaswamy, K;
... Attard, G; + view all
(2019)
Patient-reported outcomes following enzalutamide or placebo in men with non-metastatic, castration-resistant prostate cancer (PROSPER): a multicentre, randomised, double-blind, phase 3 trial.
Lancet Oncology
, 20
(4)
pp. 556-569.
10.1016/S1470-2045(18)30898-2.
|
|
Townsend, W;
Leong, S;
Hoskin, P;
Diez, P;
Patrick, P;
Linch, D;
Wong, W-L;
... Ardeshna, K; + view all
(2019)
Treatment of classical Hodgkin lymphoma in young adults aged 18-30 years with a modified paediatric Hodgkin lymphoma protocol. Results of a multicentre phase II clinical trial (CRUK/08/012).
British Journal of Haematology
10.1111/bjh.16296.
(In press).
|
|
|
Tran, M;
Latifoltojar, A;
Neves, J;
Papoutsaki, M-V;
Gong, Y;
Comment, A;
Costa, A;
... Punwani, S; + view all
(2019)
First-in-human in vivo non-invasive assessment of intra-tumoral metabolic heterogeneity in renal cell carcinoma.
BJR Case Reports
10.1259/bjrcr.20190003.
(In press).
|
|
|
Trebeschi, S;
Drago, SG;
Birkbak, NJ;
Kurilova, I;
Calin, AM;
Pizzi, AD;
Lalezari, F;
... Aerts, HJWL; + view all
(2019)
Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers.
Annals of Oncology
, 30
(6)
pp. 998-1004.
10.1093/annonc/mdz108.
|
|
U
|
Uddin, I;
Joshi, K;
Oakes, T;
Heather, JM;
Swanton, C;
TRACERx consortium, .;
Chain, B;
(2019)
An Economical, Quantitative, and Robust Protocol for High-Throughput T Cell Receptor Sequencing from Tumor or Blood.
Cancer Immunosurveillance: Methods and Protocols
pp. 15-42.
10.1007/978-1-4939-8885-3_2.
|
|
Uddin, I;
Woolston, A;
Peacock, T;
Joshi, K;
Ismail, M;
Ronel, T;
Husovsky, C;
(2019)
Quantitative analysis of the T cell receptor repertoire.
Methods in Enzymology
, 629
pp. 465-492.
10.1016/bs.mie.2019.05.054.
|
|
Unlu, O;
Erkan, D;
Barbhaiya, M;
Andrade, D;
Nascimento, I;
Rosa, R;
Banzato, A;
... APS ACTION, .; + view all
(2019)
The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody–Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and Repository.
Arthritis Care & Research
, 71
(1)
pp. 134-141.
10.1002/acr.23584.
|
|
Urkmez, E;
Andac-Jones, E;
Cibula, D;
Querleu, D;
Halaska, MJ;
Driak, D;
Sehouli, J;
... Gultekin, M; + view all
(2019)
Perceptions, expectations, and experiences of gynecological cancer patients: a pan-European ESGO-ENGAGe survey.
International Journal of Gynecological Cancer
, 29
(9)
pp. 1425-1430.
10.1136/ijgc-2019-000567.
|
|
|
Usher, I;
Flanagan, AM;
Choi, D;
(2019)
Systematic Review of Clinical, Radiologic, and Histologic Features of Benign Notochordal Cell Tumors: Implications for Patient Management.
World Neurosurgery
, 130
pp. 13-23.
10.1016/j.wneu.2019.06.009.
|
V
|
van der Wel, MJ;
Coleman, HG;
Bergman, JJGHM;
Jansen, M;
Meijer, SL;
BOLERO working group;
(2019)
Histopathologist features predictive of diagnostic concordance at expert level among a large international sample of pathologists diagnosing Barrett's dysplasia using digital pathology.
Gut
10.1136/gutjnl-2019-318985.
(In press).
|
|
|
van Dorp, L;
Wang, Q;
Shaw, LP;
Acman, M;
Brynildsrud, OB;
Eldholm, V;
Wang, R;
... Wang, H; + view all
(2019)
Rapid phenotypic evolution in multidrug-resistant Klebsiella pneumoniae hospital outbreak strains.
Microbial Genomics
10.1099/mgen.0.000263.
(In press).
|
|
|
van Noesel, MM;
Orbach, D;
Brennan, B;
Kelsey, A;
Zanetti, I;
de Salvo, GL;
Gaze, MN;
... Ferrari, A; + view all
(2019)
Outcome and prognostic factors in pediatric malignant peripheral nerve sheath tumors: An analysis of the European Pediatric Soft Tissue Sarcoma Group (EpSSG) NRSTS-2005 prospective study.
Pediatric Blood and Cancer
, 66
(10)
, Article e27833. 10.1002/pbc.27833.
|
|
|
Vanhaesebroeck, B;
Bilanges, B;
Madsen, RR;
Dale, KL;
Lau, E;
Vladimirou, E;
(2019)
Perspective: Potential Impact and Therapeutic Implications of Oncogenic PI3K Activation on Chromosomal Instability.
Biomolecules
, 9
(8)
, Article 331. 10.3390/biom9080331.
|
|
|
Vijapurapu, R;
Geberhiwot, T;
Jovanovic, A;
Baig, S;
Nordin, S;
Kozor, R;
Leyva, F;
... Steeds, RP; + view all
(2019)
Study of indications for cardiac device implantation and utilisation in Fabry cardiomyopathy.
Heart
10.1136/heartjnl-2019-315229.
(In press).
|
|
|
Vijapurapu, R;
Kozor, R;
Hughes, DA;
Woolfson, P;
Jovanovic, A;
Deegan, P;
Rusk, R;
... Steeds, RP; + view all
(2019)
A randomised controlled trial evaluating arrhythmia burden, risk of sudden cardiac death and stroke in patients with Fabry disease: the role of implantable loop recorders (RaILRoAD) compared with current standard practice.
Trials
, 20
, Article 314. 10.1186/s13063-019-3425-1.
|
|
|
Vijapurapu, R;
Nordin, S;
Baig, S;
Liu, B;
Rosmini, S;
Augusto, J;
Tchan, M;
... Kozor, R; + view all
(2019)
Global longitudinal strain, myocardial storage and hypertrophy in Fabry disease.
Heart
10.1136/heartjnl-2018-313699.
(In press).
|
|
W
|
Wagner, AK;
Alici, E;
Lowdell, MW;
(2019)
Characterization of human natural killer cells for therapeutic use.
Cytotherapy
, 21
(3)
pp. 315-326.
10.1016/j.jcyt.2018.11.001.
|
|
Webster, AK;
Hung, A;
Moore, BT;
Guzman, R;
Jordan, JM;
Kaplan, REW;
Hibshman, JD;
... Baugh, LR; + view all
(2019)
Population Selection and Sequencing of Caenorhabditis elegans Wild Isolates Identifies a Region on Chromosome III Affecting Starvation Resistance.
G3
, 9
(10)
pp. 3477-3488.
10.1534/g3.119.400617.
|
|
|
Wei, W;
Tuna, S;
Keogh, MJ;
Smith, KR;
Aitman, TJ;
Beales, PL;
Bennett, DL;
... Chinnery, PF; + view all
(2019)
Germline selection shapes human mitochondrial DNA diversity.
Science
, 364
(6442)
, Article eaau6520. 10.1126/science.aau6520.
|
|
|
Weil, B;
Hanley, PJ;
Lowdell, M;
(2019)
Proposal for the International Society for Cell & Gene Therapy position statement on assays for the quality control and potency assessment of adoptive cellular immunotherapies.
Cytotherapy
, 21
(3)
pp. 367-375.
10.1016/j.jcyt.2019.02.001.
|
|
Werner Sunderland, Mariana;
(2019)
Gene editing of tumour infiltrating lymphocytes for the generation of adoptive cellular therapeutics against cancer.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
West, Heather Carol;
(2019)
Characterising the plasticity of cutaneous myeloid cells in graft-versus-host disease.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Wheeler, G;
Pallmann, P;
Wan, F;
Mander, A;
Yap, C;
Clive, S;
Hampson, L;
(2019)
Designing and evaluating dose-escalation studies made easy: the MoDEsT web app.
Clinical Trials
10.1177/1740774519890146.
(In press).
|
|
|
Wheeler, GM;
Mander, A;
Bedding, A;
Brock, K;
Cornelius, V;
Grieve, A;
Jaki, T;
... Bond, S; + view all
(2019)
How to design a dose-finding study using the Continual Reassessment Method.
BMC Medical Research Methodology
, 19
, Article 18. 10.1186/s12874-018-0638-z.
|
|
|
Wheeler, GM;
Sweeting, M;
Mander, A;
(2019)
A Bayesian model‐free approach to combination therapy phase I trials using censored time‐to‐toxicity data.
Journal of the Royal Statistical Society: Series C (Applied Statistics)
, 68
(2)
pp. 309-329.
10.1111/rssc.12323.
|
|
White, J;
Carolan-Rees, G;
Dale, M;
Morgan, HE;
Patrick, HE;
See, TC;
Beeton, EL;
... Sharma, RA; + view all
(2019)
Analysis of a National Programme for Selective Internal Radiation Therapy for Colorectal Cancer Liver Metastases.
Clinical Oncology
, 31
(1)
pp. 58-66.
10.1016/j.clon.2018.09.002.
|
|
White, J;
Carolan-Rees, G;
Dale, M;
Patrick, HE;
See, TC;
Bell, JK;
Manas, DM;
... Sharma, RA; + view all
(2019)
Yttrium-90 Transarterial Radioembolization for Chemotherapy-Refractory Intrahepatic Cholangiocarcinoma: A Prospective, Observational Study.
Journal of Vascular and Interventional Radiology
, 30
(8)
pp. 1185-1192.
10.1016/j.jvir.2019.03.018.
|
|
Wilson, D;
Ambler, G;
Lee, K-J;
Lim, J-S;
Shiozawa, M;
Koga, M;
Li, L;
... Microbleeds International Collaborative Network, .; + view all
(2019)
Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies.
Lancet Neurology
10.1016/S1474-4422(19)30197-8.
(In press).
|
|
|
Wilson, D;
Ambler, G;
Shakeshaft, C;
Banerjee, G;
Charidimou, A;
Seiffge, D;
White, M;
... CROMIS-2 collaborators, .; + view all
(2019)
Potential missed opportunities to prevent ischaemic stroke: prospective multicentre cohort study of atrial fibrillation-associated ischaemic stroke and TIA.
BMJ Open
, 9
(7)
, Article e028387. 10.1136/bmjopen-2018-028387.
|
|
|
Winter, H;
Kaisaki, PJ;
Harvey, J;
Giacopuzzi, E;
Ferla, MP;
Pentony, MM;
Knight, SJL;
... McCullagh, JSO; + view all
(2019)
Identification of Circulating Genomic and Metabolic Biomarkers in Intrahepatic Cholangiocarcinoma.
Cancers
, 11
(12)
, Article 1895. 10.3390/cancers11121895.
|
|
|
Winter, H;
Rassam, J;
Virdee, PS;
Goldin, R;
Pitcheshwar, P;
Weaver, K;
Primrose, J;
... Sharma, RA; + view all
(2019)
Hepatic Resection Following Selective Internal Radiation Therapy for Colorectal Cancer Metastases in the FOXFIRE Clinical Trial: Clinical Outcomes and Distribution of Microspheres.
Cancers
, 11
(8)
, Article 1155. 10.3390/cancers11081155.
|
|
|
Wolf, Y;
Bartok, O;
Patkar, S;
Bar Eli, G;
Cohen, S;
Litchfield, K;
Levy, R;
... Samuels, Y; + view all
(2019)
UVB-Induced Tumor Heterogeneity Diminishes Immune Response in Melanoma.
Cell
, 179
(1)
219-235.e21.
10.1016/j.cell.2019.08.032.
|
|
|
Woodcock, HV;
Eley, JD;
Guillotin, D;
Plate, M;
Nanthakumar, CB;
Martufi, M;
Peace, S;
... Chambers, RC; + view all
(2019)
The mTORC1/4E-BP1 axis represents a critical signaling node during fibrogenesis.
Nature Communications
, 10
, Article 6. 10.1038/s41467-018-07858-8.
|
|
|
Woolston, A;
Khan, K;
Spain, G;
Barber, LJ;
Griffiths, B;
Gonzalez-Exposito, R;
Hornsteiner, L;
... Gerlinger, M; + view all
(2019)
Genomic and Transcriptomic Determinants of Therapy Resistance and Immune Landscape Evolution during Anti-EGFR Treatment in Colorectal Cancer.
Cancer Cell
, 36
(1)
35-50e9.
10.1016/j.ccell.2019.05.013.
|
|
|
Wu, A;
Attard, G;
(2019)
Plasma DNA Analysis in Prostate Cancer: Opportunities for Improving Clinical Management.
Clinical Chemistry
, 65
(1)
10.1373/clinchem.2018.287250.
|
Y
|
Yamano, H;
(2019)
APC/C: current understanding and future perspectives.
F1000Research
, 8
, Article 725. 10.12688/f1000research.18582.1.
|
|
|
Yong, K;
van de Donk, N;
(2019)
Oral proteasome inhibitor maintenance for multiple myeloma.
The Lancet
, 393
(10168)
pp. 204-205.
10.1016/S0140-6736(18)33128-3.
|
Z
|
Zhabyeyev, P;
Chen, X;
Vanhaesebroeck, B;
Oudit, GY;
(2019)
PI3Kα in cardioprotection: Cytoskeleton, late Na+ current, and mechanism of arrhythmias.
Channels
, 13
(1)
pp. 520-532.
10.1080/19336950.2019.1697127.
|
|
|
Zhabyeyev, P;
McLean, B;
Chen, X;
Vanhaesebroeck, B;
Oudit, GY;
(2019)
Inhibition of PI3Kinase-α is pro-arrhythmic and associated with enhanced late Na⁺ current, contractility, and Ca²⁺ release in murine hearts.
Journal of Molecular and Cellular Cardiology
, 132
pp. 98-109.
10.1016/j.yjmcc.2019.05.008.
|
|
Zhang, C;
Stockwell, SR;
Elbanna, M;
Ketteler, R;
Freeman, J;
Al-Lazikani, B;
Eccles, S;
... Mittnacht, S; + view all
(2019)
Signalling involving MET and FAK supports cell division independent of the activity of the cell cycle-regulating CDK4/6 kinases.
Oncogene
, 38
pp. 5905-5920.
10.1038/s41388-019-0850-2.
|
|
Zheng, SC;
Breeze, CE;
Beck, S;
Dong, D;
Zhu, T;
Ma, L;
Ye, W;
... Teschendorff, AE; + view all
(2019)
EpiDISH web server: Epigenetic Dissection of Intra-Sample-Heterogeneity with online GUI.
Bioinformatics
10.1093/bioinformatics/btz833.
(In press).
|
|
|
Zhou, L;
Ng, HK;
Drautz-Moses, DI;
Schuster, SC;
Beck, S;
Kim, C;
Chambers, JC;
(2019)
Systematic evaluation of library preparation methods and sequencing platforms for high-throughput whole genome bisulfite sequencing.
Scientific Reports
, 9
, Article 10383. 10.1038/s41598-019-46875-5.
|
|
|
Zwi-Dantsis, L;
Wang, B;
Marijon, C;
Zonetti, S;
Ferrini, A;
Massi, L;
Stuckey, DJ;
... Stevens, MM; + view all
(2019)
Remote Magnetic Nanoparticle Manipulation Enables the Dynamic Patterning of Cardiac Tissues.
Advanced Materials
, Article e1904598. 10.1002/adma.201904598.
(In press).
|
|
